| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | TMIGD1 DSCAM DSP CALR RTN4 SPTBN1 ESAM SIRPB1 PTPRD PTPRF P2RX4 EIF4G2 AFDN PLEC UTRN NOS2 CDH5 CDH11 | 4.44e-06 | 599 | 172 | 18 | GO:0050839 |
| GeneOntologyMolecularFunction | molecular tag activity | 4.97e-06 | 14 | 172 | 4 | GO:0141047 | |
| GeneOntologyMolecularFunction | protein tag activity | 4.97e-06 | 14 | 172 | 4 | GO:0031386 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.77e-04 | 230 | 172 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 1.80e-04 | 61 | 172 | 5 | GO:0098632 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase activity | 2.20e-04 | 3 | 172 | 2 | GO:0004517 | |
| GeneOntologyMolecularFunction | FMN binding | 3.24e-04 | 16 | 172 | 3 | GO:0010181 | |
| GeneOntologyMolecularFunction | tetrahydrobiopterin binding | 4.38e-04 | 4 | 172 | 2 | GO:0034617 | |
| GeneOntologyMolecularFunction | DNA topoisomerase binding | 4.38e-04 | 4 | 172 | 2 | GO:0044547 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 5.04e-04 | 76 | 172 | 5 | GO:0098631 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 8.19e-04 | 127 | 172 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 9.25e-04 | 130 | 172 | 6 | GO:0005200 | |
| GeneOntologyMolecularFunction | GTP-dependent protein binding | 1.11e-03 | 24 | 172 | 3 | GO:0030742 | |
| GeneOntologyMolecularFunction | sialic acid binding | 1.26e-03 | 25 | 172 | 3 | GO:0033691 | |
| GeneOntologyBiologicalProcess | negative regulation of phagocytosis, engulfment | 5.63e-06 | 5 | 172 | 3 | GO:0060101 | |
| GeneOntologyBiologicalProcess | negative regulation of membrane invagination | 1.12e-05 | 6 | 172 | 3 | GO:1905154 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SEMA4D MAP1A DSCAM KALRN RTN4 VPS33A DNM1L ECT2 WDR19 FAM171A1 UBB PTPRD PTPRF ATXN2 PTPRS SCN1B PTPRQ EIF4G2 AFDN TRAK2 PLEC CDH5 CDH11 EPB41 BRWD1 | 1.98e-05 | 1194 | 172 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell junction assembly | SEMA4D OGT ANK2 DSCAM PCLO RTN4 ESAM ECT2 PTPRD PTPRS AFDN PLEC ADGRL2 CDH5 CDH11 GABRA4 | 2.35e-05 | 569 | 172 | 16 | GO:0034329 |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 3.47e-05 | 148 | 172 | 8 | GO:1902414 | |
| GeneOntologyBiologicalProcess | cell junction organization | TMIGD1 SEMA4D OGT ANK2 DSCAM KALRN DSP PCLO RTN4 ESAM DNM1L ECT2 PTPRD PTPRF PTPRS AFDN PLEC ADGRL2 CDH5 CDH11 GABRA4 | 6.42e-05 | 974 | 172 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DSCAM PCDHGB7 PCDHGB5 PCDHGA9 ESAM ATP2C1 PTPRD PTPRF PTPRS CDH5 CDH11 | 6.66e-05 | 313 | 172 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | SETMAR ATRX MAP1A SIGLEC9 SIGLEC8 RTN4 SPTBN1 DNM1L SIRPB1 SIGLEC7 PTPRF ATXN2 PTPRS MYLIP MINAR1 TRAK2 IK CDH5 KNL1 | 1.13e-04 | 864 | 172 | 19 | GO:0051129 |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 1.14e-04 | 91 | 172 | 6 | GO:0060998 | |
| GeneOntologyBiologicalProcess | dendrite development | SEMA4D MAP1A DSCAM KALRN DNM1L PTPRD PTPRF PTPRS EIF4G2 AFDN TRAK2 | 1.22e-04 | 335 | 172 | 11 | GO:0016358 |
| GeneOntologyBiologicalProcess | adherens junction organization | 1.55e-04 | 61 | 172 | 5 | GO:0034332 | |
| GeneOntologyBiologicalProcess | negative regulation of phagocytosis | 1.58e-04 | 33 | 172 | 4 | GO:0050765 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine morphogenesis | 1.78e-04 | 34 | 172 | 4 | GO:0061003 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.79e-04 | 187 | 172 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 2.26e-04 | 103 | 172 | 6 | GO:0048814 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 2.30e-04 | 246 | 172 | 9 | GO:0045216 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite morphogenesis | 2.42e-04 | 67 | 172 | 5 | GO:0050775 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | SEMA4D DSCAM KALRN RTN4 TBC1D2B DNM1L PLEKHM1 PTPRD PTPRF P2RX4 PTPRS SCN1B MYLIP EIF4G2 AFDN MINAR1 TRAK2 HTT | 2.59e-04 | 846 | 172 | 18 | GO:0120035 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 2.64e-04 | 198 | 172 | 8 | GO:0048813 | |
| GeneOntologyBiologicalProcess | synapse assembly | 2.71e-04 | 308 | 172 | 10 | GO:0007416 | |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 2.78e-04 | 69 | 172 | 5 | GO:0010770 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 2.97e-04 | 70 | 172 | 5 | GO:0060999 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | SEMA4D DSCAM KALRN RTN4 TBC1D2B DNM1L PLEKHM1 PTPRD PTPRF P2RX4 PTPRS SCN1B MYLIP EIF4G2 AFDN MINAR1 TRAK2 HTT | 3.29e-04 | 863 | 172 | 18 | GO:0031344 |
| GeneOntologyBiologicalProcess | establishment of endothelial intestinal barrier | 3.56e-04 | 17 | 172 | 3 | GO:0090557 | |
| MousePheno | abnormal nervous system regeneration | 1.80e-06 | 21 | 142 | 5 | MP:0004858 | |
| MousePheno | abnormal central nervous system regeneration | 3.19e-06 | 11 | 142 | 4 | MP:0003407 | |
| MousePheno | delayed peripheral nervous system regeneration | 4.07e-06 | 4 | 142 | 3 | MP:0031330 | |
| MousePheno | enhanced central nervous system regeneration | 2.01e-05 | 6 | 142 | 3 | MP:0030013 | |
| Domain | IGc2 | TMIGD1 SEMA4D MYLK DSCAM KALRN SIGLEC8 MYOM3 ESAM MALT1 SIGLEC7 PTPRD PTPRF PTPRS ALPK2 LRIT1 | 2.31e-09 | 235 | 163 | 15 | SM00408 |
| Domain | Ig_sub2 | TMIGD1 SEMA4D MYLK DSCAM KALRN SIGLEC8 MYOM3 ESAM MALT1 SIGLEC7 PTPRD PTPRF PTPRS ALPK2 LRIT1 | 2.31e-09 | 235 | 163 | 15 | IPR003598 |
| Domain | Ig_I-set | TMIGD1 MYLK DSCAM KALRN SIGLEC8 MYOM3 ESAM SIGLEC7 PTPRD PTPRF PTPRS ALPK2 LRIT1 | 1.23e-08 | 190 | 163 | 13 | IPR013098 |
| Domain | I-set | TMIGD1 MYLK DSCAM KALRN SIGLEC8 MYOM3 ESAM SIGLEC7 PTPRD PTPRF PTPRS ALPK2 LRIT1 | 1.23e-08 | 190 | 163 | 13 | PF07679 |
| Domain | Ig-like_fold | TMIGD1 SEMA4D IL13RA2 MYLK DSCAM KALRN TRA SIGLEC9 SIGLEC8 MYOM3 ESAM SIRPB1 TGM5 IFNAR1 MALT1 SIGLEC7 PTPRD PTPRF PTPRS SCN1B NFKB2 ALPK2 LRIT1 | 5.28e-08 | 706 | 163 | 23 | IPR013783 |
| Domain | - | TMIGD1 SEMA4D IL13RA2 MYLK DSCAM KALRN SIGLEC9 SIGLEC8 MYOM3 ESAM SIRPB1 TGM5 IFNAR1 MALT1 SIGLEC7 PTPRD PTPRF PTPRS SCN1B NFKB2 ALPK2 LRIT1 | 7.70e-08 | 663 | 163 | 22 | 2.60.40.10 |
| Domain | ig | TMIGD1 SEMA4D DSCAM SIGLEC9 SIGLEC8 MYOM3 MALT1 SIGLEC7 PTPRD PTPRS SCN1B LRIT1 | 1.10e-07 | 190 | 163 | 12 | PF00047 |
| Domain | Immunoglobulin | TMIGD1 SEMA4D DSCAM SIGLEC9 SIGLEC8 MYOM3 MALT1 SIGLEC7 PTPRD PTPRS SCN1B LRIT1 | 1.10e-07 | 190 | 163 | 12 | IPR013151 |
| Domain | IG | TMIGD1 SEMA4D MYLK DSCAM KALRN SIGLEC9 SIGLEC8 MYOM3 ESAM SIRPB1 MALT1 SIGLEC7 PTPRD PTPRF PTPRS ALPK2 LRIT1 | 1.72e-07 | 421 | 163 | 17 | SM00409 |
| Domain | Ig_sub | TMIGD1 SEMA4D MYLK DSCAM KALRN SIGLEC9 SIGLEC8 MYOM3 ESAM SIRPB1 MALT1 SIGLEC7 PTPRD PTPRF PTPRS ALPK2 LRIT1 | 1.72e-07 | 421 | 163 | 17 | IPR003599 |
| Domain | IG_LIKE | TMIGD1 SEMA4D MYLK DSCAM KALRN SIGLEC9 SIGLEC8 MYOM3 ESAM SIRPB1 MALT1 SIGLEC7 PTPRD PTPRF PTPRS SCN1B ALPK2 LRIT1 | 3.05e-07 | 491 | 163 | 18 | PS50835 |
| Domain | Ig-like_dom | TMIGD1 SEMA4D MYLK DSCAM KALRN SIGLEC9 SIGLEC8 MYOM3 ESAM SIRPB1 MALT1 SIGLEC7 PTPRD PTPRF PTPRS SCN1B ALPK2 LRIT1 | 4.34e-07 | 503 | 163 | 18 | IPR007110 |
| Domain | Ubiquitin_CS | 1.13e-06 | 10 | 163 | 4 | IPR019954 | |
| Domain | Ubiquitin | 1.76e-06 | 11 | 163 | 4 | IPR019956 | |
| Domain | Spectrin_repeat | 4.77e-06 | 29 | 163 | 5 | IPR002017 | |
| Domain | SPEC | 7.92e-06 | 32 | 163 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 7.92e-06 | 32 | 163 | 5 | IPR018159 | |
| Domain | FN3 | IL13RA2 MYLK DSCAM KALRN MYOM3 IFNAR1 PTPRD PTPRF PTPRS LRIT1 | 1.01e-05 | 199 | 163 | 10 | PS50853 |
| Domain | FN3_dom | IL13RA2 MYLK DSCAM KALRN MYOM3 IFNAR1 PTPRD PTPRF PTPRS LRIT1 | 1.55e-05 | 209 | 163 | 10 | IPR003961 |
| Domain | UBIQUITIN_1 | 1.66e-05 | 37 | 163 | 5 | PS00299 | |
| Domain | Flavodoxin/NO_synth | 3.54e-05 | 8 | 163 | 3 | IPR008254 | |
| Domain | Flavdoxin-like | 3.54e-05 | 8 | 163 | 3 | IPR001094 | |
| Domain | FLAVODOXIN_LIKE | 3.54e-05 | 8 | 163 | 3 | PS50902 | |
| Domain | Flavodoxin_1 | 3.54e-05 | 8 | 163 | 3 | PF00258 | |
| Domain | FN3 | 3.65e-05 | 185 | 163 | 9 | SM00060 | |
| Domain | ubiquitin | 5.43e-05 | 47 | 163 | 5 | PF00240 | |
| Domain | - | 7.49e-05 | 10 | 163 | 3 | 3.40.50.360 | |
| Domain | Flavoprotein-like_dom | 7.49e-05 | 10 | 163 | 3 | IPR029039 | |
| Domain | fn3 | 8.97e-05 | 162 | 163 | 8 | PF00041 | |
| Domain | UBIQUITIN_2 | 1.07e-04 | 54 | 163 | 5 | PS50053 | |
| Domain | Ubiquitin_dom | 1.50e-04 | 58 | 163 | 5 | IPR000626 | |
| Domain | Ubiquitin-rel_dom | 2.16e-04 | 184 | 163 | 8 | IPR029071 | |
| Domain | NO_synthase | 2.26e-04 | 3 | 163 | 2 | PF02898 | |
| Domain | NOS_euk | 2.26e-04 | 3 | 163 | 2 | IPR012144 | |
| Domain | - | 2.26e-04 | 3 | 163 | 2 | 3.90.340.10 | |
| Domain | NOS_N | 2.26e-04 | 3 | 163 | 2 | IPR004030 | |
| Domain | NOS | 2.26e-04 | 3 | 163 | 2 | PS60001 | |
| Domain | ZF_ZZ_2 | 4.84e-04 | 18 | 163 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 4.84e-04 | 18 | 163 | 3 | PS01357 | |
| Domain | ZZ | 4.84e-04 | 18 | 163 | 3 | PF00569 | |
| Domain | UBQ | 5.29e-04 | 43 | 163 | 4 | SM00213 | |
| Domain | Znf_ZZ | 5.71e-04 | 19 | 163 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 5.71e-04 | 19 | 163 | 3 | SM00291 | |
| Domain | - | KALRN SPTBN1 TBC1D2B APBA2 ECT2 PLEKHM1 MYLIP OSBPL10 PLCH1 VAV1 EPB41 | 6.59e-04 | 391 | 163 | 11 | 2.30.29.30 |
| Domain | Autophagy-rel_C | 7.44e-04 | 5 | 163 | 2 | IPR015412 | |
| Domain | ATG_C | 7.44e-04 | 5 | 163 | 2 | PF09333 | |
| Domain | Spectrin | 1.02e-03 | 23 | 163 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.02e-03 | 23 | 163 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.02e-03 | 23 | 163 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.02e-03 | 23 | 163 | 3 | IPR001589 | |
| Domain | - | 1.11e-03 | 6 | 163 | 2 | 3.90.1290.10 | |
| Domain | FAD_binding_1 | 1.11e-03 | 6 | 163 | 2 | PF00667 | |
| Domain | - | 1.11e-03 | 6 | 163 | 2 | 1.20.990.10 | |
| Domain | FAD-binding_1 | 1.11e-03 | 6 | 163 | 2 | IPR003097 | |
| Domain | NADPH_Cyt_P450_Rdtase_dom3 | 1.11e-03 | 6 | 163 | 2 | IPR023173 | |
| Domain | PH_dom-like | KALRN SPTBN1 TBC1D2B APBA2 ECT2 PLEKHM1 MYLIP OSBPL10 PLCH1 VAV1 EPB41 | 1.32e-03 | 426 | 163 | 11 | IPR011993 |
| Domain | Clathrin | 1.54e-03 | 7 | 163 | 2 | PF00637 | |
| Domain | Plectin | 1.54e-03 | 7 | 163 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.54e-03 | 7 | 163 | 2 | IPR001101 | |
| Domain | PLEC | 1.54e-03 | 7 | 163 | 2 | SM00250 | |
| Domain | Ig_V-set | 1.85e-03 | 199 | 163 | 7 | IPR013106 | |
| Domain | Clathrin_H-chain/VPS_repeat | 2.05e-03 | 8 | 163 | 2 | IPR000547 | |
| Domain | Chorein_N | 2.05e-03 | 8 | 163 | 2 | PF12624 | |
| Domain | VPS13_N | 2.05e-03 | 8 | 163 | 2 | IPR026854 | |
| Domain | CH | 2.50e-03 | 65 | 163 | 4 | SM00033 | |
| Domain | Cadherin_CS | 2.68e-03 | 109 | 163 | 5 | IPR020894 | |
| Domain | PH | 3.11e-03 | 278 | 163 | 8 | SM00233 | |
| Domain | CADHERIN_1 | 3.13e-03 | 113 | 163 | 5 | PS00232 | |
| Domain | Cadherin | 3.13e-03 | 113 | 163 | 5 | PF00028 | |
| Domain | PH_DOMAIN | 3.18e-03 | 279 | 163 | 8 | PS50003 | |
| Domain | PH_domain | 3.25e-03 | 280 | 163 | 8 | IPR001849 | |
| Domain | MIF4G | 3.25e-03 | 10 | 163 | 2 | SM00543 | |
| Domain | MIF4G | 3.25e-03 | 10 | 163 | 2 | PF02854 | |
| Domain | MIF4G-like_typ-3 | 3.25e-03 | 10 | 163 | 2 | IPR003890 | |
| Domain | Flavoprot_Pyr_Nucl_cyt_Rdtase | 3.25e-03 | 10 | 163 | 2 | IPR001709 | |
| Domain | CADHERIN_2 | 3.26e-03 | 114 | 163 | 5 | PS50268 | |
| Domain | - | 3.26e-03 | 114 | 163 | 5 | 2.60.40.60 | |
| Domain | CH | 3.28e-03 | 70 | 163 | 4 | PF00307 | |
| Domain | CA | 3.38e-03 | 115 | 163 | 5 | SM00112 | |
| Domain | - | 3.45e-03 | 71 | 163 | 4 | 1.10.418.10 | |
| Domain | Cadherin-like | 3.51e-03 | 116 | 163 | 5 | IPR015919 | |
| Domain | Prefoldin | 3.63e-03 | 72 | 163 | 4 | IPR009053 | |
| Domain | PTPc | 3.77e-03 | 36 | 163 | 3 | SM00194 | |
| Domain | Cadherin | 3.77e-03 | 118 | 163 | 5 | IPR002126 | |
| Domain | CH | 3.81e-03 | 73 | 163 | 4 | PS50021 | |
| Domain | Cadherin_tail | 4.08e-03 | 37 | 163 | 3 | PF15974 | |
| Domain | Cadherin_CBD | 4.08e-03 | 37 | 163 | 3 | IPR031904 | |
| Domain | CH-domain | 4.20e-03 | 75 | 163 | 4 | IPR001715 | |
| Domain | Death_domain | 4.40e-03 | 38 | 163 | 3 | IPR000488 | |
| Domain | DEATH_DOMAIN | 4.40e-03 | 38 | 163 | 3 | PS50017 | |
| Domain | OxRdtase_FAD/NAD-bd | 4.72e-03 | 12 | 163 | 2 | IPR001433 | |
| Domain | NAD_binding_1 | 4.72e-03 | 12 | 163 | 2 | PF00175 | |
| Domain | TYR_PHOSPHATASE_PTP | 4.74e-03 | 39 | 163 | 3 | PS50055 | |
| Domain | PTPase_domain | 5.46e-03 | 41 | 163 | 3 | IPR000242 | |
| Domain | C2-set_2 | 5.46e-03 | 41 | 163 | 3 | PF08205 | |
| Domain | Y_phosphatase | 5.46e-03 | 41 | 163 | 3 | PF00102 | |
| Domain | CD80_C2-set | 5.46e-03 | 41 | 163 | 3 | IPR013162 | |
| Domain | OLF | 5.54e-03 | 13 | 163 | 2 | PF02191 | |
| Domain | OLF | 5.54e-03 | 13 | 163 | 2 | PS51132 | |
| Domain | Olfac-like_dom | 5.54e-03 | 13 | 163 | 2 | IPR003112 | |
| Pathway | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | 1.18e-09 | 7 | 128 | 5 | MM15592 | |
| Pathway | REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC | 6.49e-09 | 4 | 128 | 4 | MM15591 | |
| Pathway | KEGG_MEDICUS_REFERENCE_UCHL1_MEDIATED_HYDROLYSIS | 3.22e-08 | 5 | 128 | 4 | M49036 | |
| Pathway | REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION | 6.93e-08 | 13 | 128 | 5 | M29823 | |
| Pathway | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | 1.59e-07 | 15 | 128 | 5 | MM15175 | |
| Pathway | REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS | 2.22e-07 | 7 | 128 | 4 | MM15593 | |
| Pathway | REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM | 2.22e-07 | 7 | 128 | 4 | M29822 | |
| Pathway | REACTOME_FLT3_SIGNALING_BY_CBL_MUTANTS | 2.22e-07 | 7 | 128 | 4 | M41737 | |
| Pathway | REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION | 2.30e-07 | 16 | 128 | 5 | M27761 | |
| Pathway | REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION | 2.30e-07 | 16 | 128 | 5 | MM15506 | |
| Pathway | REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1 | 7.89e-07 | 9 | 128 | 4 | M27732 | |
| Pathway | REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS | 7.89e-07 | 9 | 128 | 4 | M27781 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING | 7.89e-07 | 9 | 128 | 4 | M26930 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_LOCALIZATION | 7.89e-07 | 9 | 128 | 4 | M27814 | |
| Pathway | REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 | 7.89e-07 | 9 | 128 | 4 | MM14676 | |
| Pathway | REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION | 7.89e-07 | 9 | 128 | 4 | M29819 | |
| Pathway | REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA | 7.89e-07 | 9 | 128 | 4 | M27276 | |
| Pathway | REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1 | 7.89e-07 | 9 | 128 | 4 | MM15482 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING | 7.89e-07 | 9 | 128 | 4 | MM14535 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 9.94e-07 | 85 | 128 | 8 | MM14746 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 1.03e-06 | 21 | 128 | 5 | MM15633 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_LOCALIZATION | 1.31e-06 | 10 | 128 | 4 | MM15539 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.31e-06 | 10 | 128 | 4 | MM14849 | |
| Pathway | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX | 1.31e-06 | 10 | 128 | 4 | MM15647 | |
| Pathway | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX | 1.31e-06 | 10 | 128 | 4 | M27925 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 1.33e-06 | 22 | 128 | 5 | M903 | |
| Pathway | REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS | 1.68e-06 | 23 | 128 | 5 | M29824 | |
| Pathway | REACTOME_REGULATION_OF_TBK1_IKK_MEDIATED_ACTIVATION_OF_IRF3_IRF7_UPON_TLR3_LIGATION | 2.04e-06 | 11 | 128 | 4 | M48241 | |
| Pathway | REACTOME_REGULATION_OF_BACH1_ACTIVITY | 2.04e-06 | 11 | 128 | 4 | M41833 | |
| Pathway | REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY | 2.04e-06 | 11 | 128 | 4 | M29827 | |
| Pathway | REACTOME_PEXOPHAGY | 2.04e-06 | 11 | 128 | 4 | M29846 | |
| Pathway | REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX | 2.04e-06 | 11 | 128 | 4 | M27885 | |
| Pathway | REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY | 2.04e-06 | 11 | 128 | 4 | MM15668 | |
| Pathway | REACTOME_PEXOPHAGY | 2.04e-06 | 11 | 128 | 4 | MM15673 | |
| Pathway | REACTOME_REGULATION_OF_BACH1_ACTIVITY | 2.04e-06 | 11 | 128 | 4 | MM15686 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 2.72e-06 | 97 | 128 | 8 | M9400 | |
| Pathway | REACTOME_JOSEPHIN_DOMAIN_DUBS | 3.03e-06 | 12 | 128 | 4 | M27577 | |
| Pathway | REACTOME_JOSEPHIN_DOMAIN_DUBS | 3.03e-06 | 12 | 128 | 4 | MM15288 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 3.03e-06 | 12 | 128 | 4 | MM14550 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 3.22e-06 | 70 | 128 | 7 | MM14824 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 3.22e-06 | 26 | 128 | 5 | MM14878 | |
| Pathway | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | 3.22e-06 | 26 | 128 | 5 | M907 | |
| Pathway | REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS | 3.92e-06 | 27 | 128 | 5 | M29816 | |
| Pathway | REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES | 4.35e-06 | 13 | 128 | 4 | MM14827 | |
| Pathway | REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | 4.35e-06 | 13 | 128 | 4 | MM14828 | |
| Pathway | REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION | 4.35e-06 | 13 | 128 | 4 | MM15280 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 4.35e-06 | 13 | 128 | 4 | M549 | |
| Pathway | REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA | 4.35e-06 | 13 | 128 | 4 | MM14931 | |
| Pathway | REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES | 4.35e-06 | 13 | 128 | 4 | M14582 | |
| Pathway | REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7 | 4.35e-06 | 13 | 128 | 4 | M27884 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | 4.35e-06 | 13 | 128 | 4 | M967 | |
| Pathway | REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | 4.35e-06 | 13 | 128 | 4 | M736 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 4.74e-06 | 28 | 128 | 5 | M41724 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 5.61e-06 | 76 | 128 | 7 | M19832 | |
| Pathway | REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7 | 6.05e-06 | 14 | 128 | 4 | M48239 | |
| Pathway | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | 6.05e-06 | 14 | 128 | 4 | MM14826 | |
| Pathway | REACTOME_GLYCOGEN_SYNTHESIS | 6.05e-06 | 14 | 128 | 4 | M27247 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FLT3 | 6.05e-06 | 14 | 128 | 4 | MM15682 | |
| Pathway | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | 6.05e-06 | 14 | 128 | 4 | M935 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR | 6.05e-06 | 14 | 128 | 4 | M47975 | |
| Pathway | REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING | 6.05e-06 | 14 | 128 | 4 | MM15642 | |
| Pathway | REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX | 6.78e-06 | 30 | 128 | 5 | M26898 | |
| Pathway | REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX | 6.78e-06 | 30 | 128 | 5 | MM14476 | |
| Pathway | REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL | 8.19e-06 | 15 | 128 | 4 | M27774 | |
| Pathway | REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7 | 8.19e-06 | 15 | 128 | 4 | MM17228 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | 8.19e-06 | 15 | 128 | 4 | MM14875 | |
| Pathway | REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA | 8.19e-06 | 15 | 128 | 4 | M27229 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FLT3 | 8.19e-06 | 15 | 128 | 4 | M41735 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 8.19e-06 | 15 | 128 | 4 | M27202 | |
| Pathway | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | 8.19e-06 | 15 | 128 | 4 | MM15645 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 9.44e-06 | 32 | 128 | 5 | MM14707 | |
| Pathway | REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS | 9.44e-06 | 32 | 128 | 5 | M29666 | |
| Pathway | REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION | 1.08e-05 | 16 | 128 | 4 | M27567 | |
| Pathway | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | 1.08e-05 | 16 | 128 | 4 | M7257 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 1.08e-05 | 16 | 128 | 4 | MM14873 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | 1.08e-05 | 16 | 128 | 4 | M627 | |
| Pathway | REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX | 1.08e-05 | 16 | 128 | 4 | M1000 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 1.08e-05 | 16 | 128 | 4 | MM14903 | |
| Pathway | REACTOME_ASSEMBLY_OF_THE_HIV_VIRION | 1.08e-05 | 16 | 128 | 4 | M27033 | |
| Pathway | REACTOME_GLYCOGEN_STORAGE_DISEASES | 1.08e-05 | 16 | 128 | 4 | M27236 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR | 1.08e-05 | 16 | 128 | 4 | M47978 | |
| Pathway | REACTOME_P75NTR_SIGNALS_VIA_NF_KB | 1.08e-05 | 16 | 128 | 4 | M18175 | |
| Pathway | REACTOME_P75NTR_SIGNALS_VIA_NF_KB | 1.08e-05 | 16 | 128 | 4 | MM14742 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 1.08e-05 | 16 | 128 | 4 | MM14541 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 1.08e-05 | 16 | 128 | 4 | M514 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 1.10e-05 | 33 | 128 | 5 | MM14666 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 1.24e-05 | 57 | 128 | 6 | MM15298 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 1.29e-05 | 34 | 128 | 5 | MM15566 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 1.29e-05 | 34 | 128 | 5 | MM15631 | |
| Pathway | REACTOME_TRANSLESION_SYNTHESIS_BY_POLK | 1.41e-05 | 17 | 128 | 4 | M27537 | |
| Pathway | REACTOME_TRANSLESION_SYNTHESIS_BY_POLK | 1.41e-05 | 17 | 128 | 4 | MM15259 | |
| Pathway | REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING | 1.41e-05 | 17 | 128 | 4 | MM15702 | |
| Pathway | REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX | 1.41e-05 | 17 | 128 | 4 | MM15648 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 1.49e-05 | 35 | 128 | 5 | M48246 | |
| Pathway | REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS | 1.49e-05 | 35 | 128 | 5 | MM15168 | |
| Pathway | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | 1.49e-05 | 35 | 128 | 5 | M918 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 1.72e-05 | 36 | 128 | 5 | M633 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION | 1.80e-05 | 18 | 128 | 4 | MM15342 | |
| Pathway | REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING | 1.80e-05 | 18 | 128 | 4 | M45023 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 1.80e-05 | 18 | 128 | 4 | MM15680 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RAPGEF6 ANK2 ATRX MAP1A ZFYVE16 DSP RBBP6 ATAD5 ZCCHC8 RTN4 ATG2B DNM1L ICE1 RPS27A PFKM SRCAP EMSY AKAP12 ORC2 YEATS2 MSH6 EIF4G2 UTRN EPB41 TP53BP1 KNL1 | 1.46e-12 | 934 | 174 | 26 | 33916271 |
| Pubmed | DNAJC13 ZEB1 RAPGEF6 OGT ZFYVE16 DSP ZCCHC8 ZGRF1 UBR4 ATG2B ICE1 BIRC6 YEATS2 ZZZ3 AMOT PLEC UTRN KNL1 | 4.61e-12 | 418 | 174 | 18 | 34709266 | |
| Pubmed | RAPGEF6 OGT DSP RBBP6 ATG2B SRCAP EMSY YEATS2 MSH6 UBA52 ZZZ3 CEBPZ AMOT AFDN QSER1 IK EPB41 TP53BP1 HTT RPAP2 | 5.91e-12 | 549 | 174 | 20 | 38280479 | |
| Pubmed | DMXL2 DCAF6 ANK2 KALRN DSP SPTBN1 PEG3 MYOM3 ECT2 BIRC6 AKAP12 UBB UBC UPF2 AMOT EIF4G2 PLEC UTRN | 7.87e-11 | 497 | 174 | 18 | 23414517 | |
| Pubmed | DMXL2 DNAJC13 ZEB1 OGT ANK2 DSCAM KALRN SPTBN1 UBR4 DNM1L SIRPB1 RPS27A EMSY AKAP12 FAM171A1 PTPRD ATXN2 PTPRS AFDN QSER1 HERC2 NOS1 CDH11 TP53BP1 | 1.10e-10 | 963 | 174 | 24 | 28671696 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | OGT ATRX MAP1A DSP RBBP6 ZCCHC8 ZGRF1 TBC1D2B SRCAP EMSY YEATS2 UBB UBC ZZZ3 NFKB2 TOPORS TP53BP1 KNL1 RPAP2 | 1.57e-10 | 588 | 174 | 19 | 38580884 |
| Pubmed | ATRX ZFYVE16 RBBP6 ZCCHC8 SPTBN1 UBR4 RPS27A UBA52 UBB UBC PTPRF EIF4G2 AFDN PLEC HERC2 TOPORS KIF13A UTRN KNL1 | 1.71e-10 | 591 | 174 | 19 | 15231748 | |
| Pubmed | MYH1 MYLK ANK2 ATRX PCDHGB7 PCDHGB5 DSP PCDHGA9 PCLO SPTBN1 UBR4 RPS27A PFKM SRCAP TASOR2 MIPOL1 RFTN1 UBA52 UBB UBC OR13D1 CEBPZ KRT20 MYH15 PLEC PLCH1 ATP1A4 CCDC191 | 7.98e-10 | 1442 | 174 | 28 | 35575683 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | ANK2 SPTBN1 RPS27A TASOR2 MSH6 UBA52 UBB UBC CEBPZ TRMT1L PLEC ATP1A4 TP53BP1 | 1.31e-09 | 271 | 174 | 13 | 32433965 |
| Pubmed | SEMA4D DMXL2 SETMAR DCAF6 OGT ANK2 ATRX DSCAM KALRN DSP ZCCHC8 SPTBN1 UBR4 PEG3 APBA2 RPS27A MIPOL1 WDR19 UBC PTPRD EIF4G2 AFDN PLEC HERC2 UTRN BRWD1 | 1.47e-09 | 1285 | 174 | 26 | 35914814 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ATRX DSP RBBP6 ATAD5 ICE1 RPS27A EMSY TASOR2 ORC2 YEATS2 UBA52 ZZZ3 ATXN2 CEBPZ EIF4G2 SGO2 AFDN QSER1 IK EPB41 TP53BP1 KNL1 | 2.92e-09 | 954 | 174 | 22 | 36373674 |
| Pubmed | DNAJC13 ZFYVE16 DSP ATAD5 CALR CEP162 SPTBN1 BIRC6 FAM171A1 MSH6 RFTN1 PTPRD PTPRF ATXN2 CEBPZ PTPRS HERC2 IK ADGRL2 UTRN PLK4 KNL1 WDR48 | 3.21e-09 | 1049 | 174 | 23 | 27880917 | |
| Pubmed | RAPGEF6 OGT ATRX CEP162 SPTBN1 PEG3 PHTF2 DNM1L SRCAP FOXJ3 AKAP12 UBC P2RX4 AMOT EIF4G2 TYW1 QSER1 PLEC IK KIF13A UTRN TP53BP1 BRWD1 | 5.94e-09 | 1084 | 174 | 23 | 11544199 | |
| Pubmed | PRPSAP1 ERCC2 OGT DSP CEP162 TBC1D2B ESAM ERICH6B NFKB2 PLEC DNAH5 | 1.24e-08 | 214 | 174 | 11 | 22199357 | |
| Pubmed | Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). | 2.15e-08 | 60 | 174 | 7 | 12787561 | |
| Pubmed | DCAF6 ERCC2 OGT MAP1A RBBP6 ATAD5 ZCCHC8 APBA2 SIRPB1 SRCAP YEATS2 MALT1 MSH6 ATP2C1 ZZZ3 ADGRL2 TOPORS VAV1 KNL1 BRWD1 RPAP2 WDR48 | 4.78e-08 | 1116 | 174 | 22 | 31753913 | |
| Pubmed | DMXL2 ANK2 MAP1A KALRN DSP PCLO RTN4 SPTBN1 UBR4 VPS33A ATG2B APBA2 RPS27A BIRC6 ATP2C1 EIF4G2 AFDN PLEC GFM1 NOS1 EPB41 TP53BP1 | 6.82e-08 | 1139 | 174 | 22 | 36417873 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DNAJC13 ZEB1 RAPGEF6 ATRX DSP RBBP6 ZCCHC8 SPTBN1 YTHDC1 EMSY YEATS2 CCNT2 MSH6 EIF4G2 AFDN PLEC TOPORS TP53BP1 | 7.78e-08 | 774 | 174 | 18 | 15302935 |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 1.23e-07 | 3 | 174 | 3 | 33656439 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 32751694 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 9784606 | ||
| Pubmed | Structure of tetraubiquitin shows how multiubiquitin chains can be formed. | 1.23e-07 | 3 | 174 | 3 | 8107144 | |
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 1321656 | ||
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 1.23e-07 | 3 | 174 | 3 | 31985401 | |
| Pubmed | HSJ1 is a neuronal shuttling factor for the sorting of chaperone clients to the proteasome. | 1.24e-07 | 10 | 174 | 4 | 15936278 | |
| Pubmed | The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. | 1.24e-07 | 10 | 174 | 4 | 11231585 | |
| Pubmed | 1.24e-07 | 10 | 174 | 4 | 10882101 | ||
| Pubmed | 1.40e-07 | 162 | 174 | 9 | 25826454 | ||
| Pubmed | 1.79e-07 | 26 | 174 | 5 | 11931757 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 1.91e-07 | 168 | 174 | 9 | 30631154 | |
| Pubmed | 1.94e-07 | 11 | 174 | 4 | 7832766 | ||
| Pubmed | 2.20e-07 | 284 | 174 | 11 | 29459677 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 27494323 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 37460871 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 24391502 | ||
| Pubmed | Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells. | 4.91e-07 | 4 | 174 | 3 | 30130255 | |
| Pubmed | Siglec receptors impact mammalian lifespan by modulating oxidative stress. | 4.91e-07 | 4 | 174 | 3 | 25846707 | |
| Pubmed | Immunosuppressive Siglec-E ligands on mouse aorta are up-regulated by LPS via NF-κB pathway. | 4.91e-07 | 4 | 174 | 3 | 31918287 | |
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 19552697 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 37467314 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 8524829 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 37492129 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 33007530 | ||
| Pubmed | Regulation of follitropin receptor cell surface residency by the ubiquitin-proteasome pathway. | 4.91e-07 | 4 | 174 | 3 | 12960054 | |
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 30910970 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 34878295 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 26047932 | ||
| Pubmed | Siglec genes confer resistance to systemic lupus erythematosus in humans and mice. | 4.91e-07 | 4 | 174 | 3 | 29503442 | |
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 25225409 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 38990656 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 38454157 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 27920204 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 21835922 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 34155121 | ||
| Pubmed | Polysialic acid and Siglec-E orchestrate negative feedback regulation of microglia activation. | 4.91e-07 | 4 | 174 | 3 | 32725371 | |
| Pubmed | Ablation of Siglec-E augments brain inflammation and ischemic injury. | 4.91e-07 | 4 | 174 | 3 | 35858866 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ATRX SPTBN1 UBR4 DNM1L PFKM SRCAP MSH6 EIF4G2 TRMT1L PLEC TP53BP1 | 1.03e-06 | 332 | 174 | 11 | 32786267 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH1 DSP VPS13C PCLO UBR4 MYOM3 PBX4 ICE1 ECT2 BIRC6 MIPOL1 MSH6 ZZZ3 AMOT KRT20 UTRN | 1.03e-06 | 736 | 174 | 16 | 29676528 |
| Pubmed | 1.05e-06 | 16 | 174 | 4 | 15721744 | ||
| Pubmed | NF-kappaB functions in the nervous system: from development to disease. | 1.05e-06 | 16 | 174 | 4 | 16997282 | |
| Pubmed | DSP CALR ZCCHC8 SPTBN1 UBR4 BIRC6 TASOR2 MSH6 CEBPZ AFDN PLEC HERC2 IK UTRN TP53BP1 | 1.16e-06 | 653 | 174 | 15 | 22586326 | |
| Pubmed | 1.22e-06 | 5 | 174 | 3 | 24895121 | ||
| Pubmed | Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. | 1.22e-06 | 5 | 174 | 3 | 10995389 | |
| Pubmed | 1.22e-06 | 5 | 174 | 3 | 10777529 | ||
| Pubmed | Exploring epistatic relationships of NO biosynthesis pathway genes in susceptibility to CHD. | 1.22e-06 | 5 | 174 | 3 | 20581851 | |
| Pubmed | 1.22e-06 | 5 | 174 | 3 | 24924635 | ||
| Pubmed | 1.22e-06 | 5 | 174 | 3 | 24045940 | ||
| Pubmed | Siglec-E Negatively Regulates the Activation of TLR4 by Controlling Its Endocytosis. | 1.22e-06 | 5 | 174 | 3 | 27619995 | |
| Pubmed | 1.22e-06 | 5 | 174 | 3 | 16857734 | ||
| Pubmed | 1.22e-06 | 5 | 174 | 3 | 19933851 | ||
| Pubmed | Siglec-9 modulated IL-4 responses in the macrophage cell line RAW264. | 1.22e-06 | 5 | 174 | 3 | 26540411 | |
| Pubmed | The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsis. | 1.22e-06 | 5 | 174 | 3 | 37890368 | |
| Pubmed | 1.22e-06 | 5 | 174 | 3 | 24227736 | ||
| Pubmed | 1.22e-06 | 5 | 174 | 3 | 22357843 | ||
| Pubmed | 1.37e-06 | 17 | 174 | 4 | 12609980 | ||
| Pubmed | 1.49e-06 | 277 | 174 | 10 | 30745168 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DNAJC13 ATRX DSP SPTBN1 VPS33A DNM1L PFKM ECT2 ORC2 MSH6 TRMT1L PLEC IK KNL1 | 1.56e-06 | 582 | 174 | 14 | 20467437 |
| Pubmed | DMXL2 DNAJC13 ANK2 ATRX ATAD5 CALR RTN4 SPTBN1 UBR4 RPS27A PFKM AKAP12 WDR19 FAM204A FAM171A1 CEBPZ EIF4G2 TYW1 DDHD2 HERC2 PLCH1 ADGRL2 TP53BP1 | 1.63e-06 | 1487 | 174 | 23 | 33957083 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAPGEF6 DSP ZCCHC8 CEP162 SPTBN1 DNM1L ECT2 FAM171A1 AMOT OSBPL10 AFDN PLEC PLCH1 KIF13A UTRN PLK4 EPB41 | 1.73e-06 | 861 | 174 | 17 | 36931259 |
| Pubmed | DMXL2 DNAJC13 ZFYVE16 VPS13C RTN4 VPS33A ATG2B PLEKHM1 AKAP12 FAM171A1 OSBPL10 TYW1 ADGRL2 | 1.74e-06 | 504 | 174 | 13 | 34432599 | |
| Pubmed | RBBP6 CALR ZCCHC8 SPTBN1 DNM1L SRCAP ORC2 YEATS2 MSH6 ZZZ3 IK UTRN TP53BP1 | 1.82e-06 | 506 | 174 | 13 | 30890647 | |
| Pubmed | 2.43e-06 | 6 | 174 | 3 | 19273906 | ||
| Pubmed | 2.43e-06 | 6 | 174 | 3 | 23315163 | ||
| Pubmed | 2.43e-06 | 6 | 174 | 3 | 8702753 | ||
| Pubmed | A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics. | 2.43e-06 | 6 | 174 | 3 | 16874301 | |
| Pubmed | 2.43e-06 | 6 | 174 | 3 | 11278955 | ||
| Pubmed | Localization of ubiquitin gene family members to mouse chromosomes 5, 11, and 18. | 2.75e-06 | 20 | 174 | 4 | 9321482 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | DNAJC13 ZEB1 DSP RBBP6 CALR RTN4 SPTBN1 CYP20A1 YTHDC1 ORC2 CCNT2 ATP2C1 PTPRF ATXN2 CEBPZ AMOT AFDN PLEC TOPORS TP53BP1 | 2.83e-06 | 1203 | 174 | 20 | 29180619 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | ATAD5 ZCCHC8 DNM1L ORC2 MSH6 ATXN2 CEBPZ TRMT1L PLEC IK VAV1 | 2.92e-06 | 370 | 174 | 11 | 22922362 |
| Pubmed | DMXL2 DNAJC13 OGT ANK2 MAP1A KALRN DSP PCLO RTN4 SPTBN1 DNM1L PFKM UPF2 PTPRS AMOT EIF4G2 OSBPL10 AFDN PLEC PLCH1 NOS1 UTRN | 3.08e-06 | 1431 | 174 | 22 | 37142655 | |
| Pubmed | ANK2 ZFYVE16 DSP RTN4 SPTBN1 ATG2B DNM1L AKAP12 FAM171A1 EIF4G2 ARHGAP29 AFDN PLCH1 ADGRL2 EPB41 | 3.11e-06 | 708 | 174 | 15 | 39231216 | |
| Pubmed | 3.44e-06 | 46 | 174 | 5 | 19190083 | ||
| Pubmed | 3.44e-06 | 46 | 174 | 5 | 35022314 | ||
| Pubmed | 4.24e-06 | 7 | 174 | 3 | 11171044 | ||
| Pubmed | 4.24e-06 | 7 | 174 | 3 | 12376545 | ||
| Pubmed | Paired Siglec receptors generate opposite inflammatory responses to a human-specific pathogen. | 4.24e-06 | 7 | 174 | 3 | 28100677 | |
| Pubmed | 4.24e-06 | 7 | 174 | 3 | 15048729 | ||
| Pubmed | [Functions and molecular evolution of Siglecs, a family of sialic acid receptor proteins]. | 4.24e-06 | 7 | 174 | 3 | 18453149 | |
| Pubmed | 4.24e-06 | 7 | 174 | 3 | 29073098 | ||
| Interaction | KDM1A interactions | VPS11 DNAJC13 ZEB1 RAPGEF6 OGT ZFYVE16 DSP ZCCHC8 CEP162 ZGRF1 UBR4 ATG2B PBX4 ICE1 ECT2 BIRC6 FAM204A YEATS2 MALT1 MSH6 UBB ZZZ3 AMOT MYLIP ARHGAP29 PLEC IK UTRN TP53BP1 HTT KNL1 | 8.57e-11 | 941 | 172 | 31 | int:KDM1A |
| Interaction | RCOR1 interactions | DNAJC13 RAPGEF6 OGT ZFYVE16 DSP ZCCHC8 ZGRF1 UBR4 VPS33A ATG2B ICE1 YTHDC1 BIRC6 YEATS2 MSH6 ZZZ3 AMOT PLEC UTRN TP53BP1 KNL1 | 1.56e-09 | 494 | 172 | 21 | int:RCOR1 |
| Interaction | PHF21A interactions | DNAJC13 RAPGEF6 OGT ZFYVE16 DSP ZCCHC8 ZGRF1 UBR4 ATG2B ICE1 BIRC6 YEATS2 ZZZ3 AMOT PLEC UTRN KNL1 | 6.54e-09 | 343 | 172 | 17 | int:PHF21A |
| Interaction | NAA40 interactions | RAPGEF6 ANK2 ATRX MAP1A ZFYVE16 DSP RBBP6 ATAD5 ZCCHC8 RTN4 ATG2B DNM1L ICE1 RPS27A PFKM SRCAP EMSY AKAP12 ORC2 YEATS2 MSH6 UBA52 EIF4G2 UTRN EPB41 TP53BP1 KNL1 | 6.72e-08 | 978 | 172 | 27 | int:NAA40 |
| Interaction | TEDC2 interactions | OGT DSP SPTBN1 VPS33A PEG3 ICE1 RPS27A UBA52 UBB UBC AFDN PLEC | 2.14e-07 | 206 | 172 | 12 | int:TEDC2 |
| Interaction | PFN1 interactions | DNAJC13 RAPGEF6 ANK2 MAP1A CALR VPS13C PCLO SPTBN1 TBC1D2B DNM1L BIRC6 UBB ARHGAP29 AFDN KIF13A TP53BP1 HTT RPAP2 | 3.87e-07 | 509 | 172 | 18 | int:PFN1 |
| Interaction | WWTR1 interactions | ZEB1 RAPGEF6 OGT ATG2B SRCAP EMSY YEATS2 MSH6 ZZZ3 CEBPZ AMOT AFDN QSER1 EPB41 TP53BP1 HTT | 7.13e-07 | 422 | 172 | 16 | int:WWTR1 |
| Interaction | MMEL1 interactions | 6.03e-06 | 5 | 172 | 3 | int:MMEL1 | |
| Interaction | PCNT interactions | DMXL2 KALRN CEP162 SPTBN1 UBC AMOT OSBPL10 PLEC UTRN PLK4 TP53BP1 | 7.40e-06 | 241 | 172 | 11 | int:PCNT |
| Interaction | CIAO1 interactions | ERCC2 DSP RBBP6 VPS13C RTN4 POLR3A CCDC7 FAM171A1 UBA52 TYW1 KNL1 RPAP2 | 7.41e-06 | 289 | 172 | 12 | int:CIAO1 |
| Interaction | PSMD14 interactions | DSP PCLO SPTBN1 UBR4 CCDC92 RPS27A UBA52 UBB UBC PLEC HERC2 DNAH5 NOS2 TP53BP1 HTT KNL1 | 1.22e-05 | 527 | 172 | 16 | int:PSMD14 |
| Interaction | LAMTOR1 interactions | DNAJC13 ZFYVE16 VPS13C SPTBN1 VPS33A TBC1D2B PFKM PLEKHM1 FAM171A1 RFTN1 UBA52 ATP2C1 PTPRD PTPRF DDHD2 PLCH1 ADGRL2 ARL14 HTT | 1.38e-05 | 722 | 172 | 19 | int:LAMTOR1 |
| Interaction | C6orf141 interactions | 1.39e-05 | 92 | 172 | 7 | int:C6orf141 | |
| Interaction | SMC5 interactions | MYH1 ATRX DSP RBBP6 ATAD5 ICE1 RPS27A EMSY TASOR2 ORC2 YEATS2 UBA52 ZZZ3 ATXN2 CEBPZ EIF4G2 SGO2 AFDN QSER1 IK EPB41 TP53BP1 KNL1 | 1.45e-05 | 1000 | 172 | 23 | int:SMC5 |
| Interaction | FLOT1 interactions | ANK2 PCLO SPTBN1 ECT2 AKAP12 FAM171A1 UBA52 MYH15 PLEC PLCH1 ADGRL2 UTRN VAV1 EPB41 HTT | 1.46e-05 | 475 | 172 | 15 | int:FLOT1 |
| Interaction | ZUP1 interactions | 1.91e-05 | 174 | 172 | 9 | int:ZUP1 | |
| Interaction | SPAST interactions | 2.23e-05 | 136 | 172 | 8 | int:SPAST | |
| Interaction | H2BC5 interactions | PCDHGB7 PCDHGB5 PCDHGA9 VPS13C PCLO RPS27A MSH6 UBA52 UBB PTPRF CEBPZ ERICH6B | 2.86e-05 | 331 | 172 | 12 | int:H2BC5 |
| Interaction | CEP120 interactions | 3.50e-05 | 106 | 172 | 7 | int:CEP120 | |
| Interaction | NPHP4 interactions | 3.66e-05 | 236 | 172 | 10 | int:NPHP4 | |
| Interaction | OFD1 interactions | DSP CEP162 TBC1D2B ICE1 ECT2 AKAP12 AMOT AFDN TRAK2 CEP126 PLK4 RPAP2 | 4.52e-05 | 347 | 172 | 12 | int:OFD1 |
| Interaction | SUMO2 interactions | ATRX KALRN CALR SPTBN1 UBR4 DNM1L PFKM SRCAP MSH6 UBB EIF4G2 TRMT1L PLEC TOPORS TP53BP1 HTT | 4.88e-05 | 591 | 172 | 16 | int:SUMO2 |
| Interaction | MYCBP2 interactions | DCAF6 ANK2 SPTBN1 UBR4 ECT2 AKAP12 MYLIP HERC2 NOS2 PLK4 ALPK2 WDR48 | 5.63e-05 | 355 | 172 | 12 | int:MYCBP2 |
| Interaction | PTPRQ interactions | 5.63e-05 | 25 | 172 | 4 | int:PTPRQ | |
| Interaction | TMIGD1 interactions | 7.24e-05 | 2 | 172 | 2 | int:TMIGD1 | |
| Interaction | C11orf52 interactions | SPTBN1 AKAP12 FAM171A1 RFTN1 UBA52 PTPRF AMOT PLCH1 ADGRL2 UTRN EPB41 | 7.72e-05 | 311 | 172 | 11 | int:C11orf52 |
| Interaction | PLEC interactions | TMIGD1 MAP1A DSCAM ECT2 MALT1 UBC QSER1 PLEC HERC2 DNAH5 NOS2 VAV1 HTT | 8.58e-05 | 430 | 172 | 13 | int:PLEC |
| Interaction | NUB1 interactions | 8.80e-05 | 53 | 172 | 5 | int:NUB1 | |
| Interaction | NUP43 interactions | DSCAM DSP RBBP6 ICE1 CCDC168 SRCAP YTHDC1 EMSY TASOR2 YEATS2 CCNT2 ZZZ3 CEBPZ EIF4G2 TRMT1L KNL1 | 9.41e-05 | 625 | 172 | 16 | int:NUP43 |
| Interaction | ASH2L interactions | 9.66e-05 | 265 | 172 | 10 | int:ASH2L | |
| Interaction | ACTC1 interactions | OGT MYLK RBBP6 CALR ZCCHC8 SPTBN1 DNM1L SRCAP ECT2 ORC2 YEATS2 MSH6 ZZZ3 PLEC IK UTRN TP53BP1 | 9.66e-05 | 694 | 172 | 17 | int:ACTC1 |
| Interaction | HYPK interactions | 1.00e-04 | 125 | 172 | 7 | int:HYPK | |
| Interaction | OCLN interactions | DNAJC13 RAPGEF6 OGT ANK2 SPTBN1 AKAP12 FAM171A1 UBA52 AFDN PLCH1 ADGRL2 UTRN EPB41 ARL14 | 1.03e-04 | 500 | 172 | 14 | int:OCLN |
| Interaction | KRT8 interactions | MYH1 RAPGEF6 OGT DSP CEP162 UBR4 TBC1D2B BIRC6 ZNF804B KRT20 PLEC NOS2 RPAP2 | 1.10e-04 | 441 | 172 | 13 | int:KRT8 |
| Interaction | PPP5C interactions | 1.20e-04 | 272 | 172 | 10 | int:PPP5C | |
| Interaction | RAB35 interactions | VPS13C SPTBN1 TBC1D2B AKAP12 FAM171A1 RFTN1 UBA52 PTPRF PTPRS AMOT PLCH1 ADGRL2 UTRN EPB41 HTT | 1.23e-04 | 573 | 172 | 15 | int:RAB35 |
| Interaction | ARRDC3 interactions | 1.35e-04 | 224 | 172 | 9 | int:ARRDC3 | |
| Interaction | ZFYVE19 interactions | 1.36e-04 | 58 | 172 | 5 | int:ZFYVE19 | |
| Interaction | OMG interactions | 1.64e-04 | 13 | 172 | 3 | int:OMG | |
| Interaction | KCNA3 interactions | ANK2 ZFYVE16 DSP RBBP6 RTN4 SPTBN1 ATG2B DNM1L PFKM AKAP12 FAM171A1 YEATS2 EIF4G2 ARHGAP29 AFDN PLCH1 ADGRL2 DNAH5 EPB41 | 1.69e-04 | 871 | 172 | 19 | int:KCNA3 |
| Interaction | LCK interactions | KALRN DSP SPTBN1 PFKM LAX1 IFNAR1 FAM171A1 PTPRF AMOT PLCH1 UTRN NOS2 VAV1 | 1.78e-04 | 463 | 172 | 13 | int:LCK |
| Interaction | HDAC1 interactions | MYH1 DNAJC13 ZEB1 RAPGEF6 OGT ATRX ZFYVE16 ZCCHC8 ZGRF1 UBR4 ATG2B RPS27A BIRC6 EMSY POLR3A YEATS2 MSH6 ZZZ3 AMOT PLEC UTRN KNL1 | 1.95e-04 | 1108 | 172 | 22 | int:HDAC1 |
| Interaction | TFCP2L1 interactions | 2.06e-04 | 99 | 172 | 6 | int:TFCP2L1 | |
| Interaction | MYOM3 interactions | 2.08e-04 | 14 | 172 | 3 | int:MYOM3 | |
| Interaction | POLR1E interactions | OGT ATAD5 ZCCHC8 ICE1 SRCAP EMSY POLR3A CEBPZ NFKB2 SGO2 RPAP2 | 2.17e-04 | 350 | 172 | 11 | int:POLR1E |
| Interaction | CBR1 interactions | 2.21e-04 | 142 | 172 | 7 | int:CBR1 | |
| Interaction | RELT interactions | 2.33e-04 | 65 | 172 | 5 | int:RELT | |
| Interaction | RAD51 interactions | 2.34e-04 | 241 | 172 | 9 | int:RAD51 | |
| Interaction | PARD3 interactions | RAPGEF6 ECT2 FAM171A1 AMOT ARHGAP29 AFDN PLCH1 ADGRL2 UTRN HTT | 2.50e-04 | 298 | 172 | 10 | int:PARD3 |
| Interaction | RAD9A interactions | 2.51e-04 | 66 | 172 | 5 | int:RAD9A | |
| Interaction | CDH11 interactions | 2.58e-04 | 15 | 172 | 3 | int:CDH11 | |
| Interaction | CHEK1 interactions | 2.64e-04 | 245 | 172 | 9 | int:CHEK1 | |
| Interaction | NOS1 interactions | 2.69e-04 | 67 | 172 | 5 | int:NOS1 | |
| Interaction | PSMC5 interactions | OGT CALR ZCCHC8 UBR4 DNM1L CCDC92 RPS27A BIRC6 UBA52 UBC NOS2 TP53BP1 HTT | 2.74e-04 | 484 | 172 | 13 | int:PSMC5 |
| Interaction | TERF2IP interactions | ZEB1 OGT RBBP6 ATAD5 ZCCHC8 SRCAP ECT2 EMSY TASOR2 YEATS2 ZZZ3 QSER1 IK KNL1 | 2.86e-04 | 552 | 172 | 14 | int:TERF2IP |
| Interaction | RAC1 interactions | PRPSAP1 ZFYVE16 KALRN SPTBN1 TBC1D2B RPS27A PFKM ECT2 AKAP12 FAM171A1 UBB UBC PTPRF PTPRS OSBPL10 QSER1 ADGRL2 UTRN NOS2 VAV1 HTT | 2.95e-04 | 1063 | 172 | 21 | int:RAC1 |
| Interaction | POLR1G interactions | OGT ATAD5 ZCCHC8 UBR4 ICE1 SRCAP POLR3A CEBPZ NFKB2 SGO2 TRMT1L IK RPAP2 | 3.02e-04 | 489 | 172 | 13 | int:POLR1G |
| Interaction | RHOB interactions | RAPGEF6 MAP1A ZFYVE16 SPTBN1 TBC1D2B ECT2 AKAP12 FAM171A1 RFTN1 UBA52 UBB PTPRF PTPRS ARHGAP29 AFDN PLCH1 ADGRL2 UTRN | 3.14e-04 | 840 | 172 | 18 | int:RHOB |
| Interaction | SYNGAP1 interactions | DMXL2 ANK2 MAP1A DSCAM KALRN RTN4 SPTBN1 DNM1L BIRC6 TP53BP1 | 3.17e-04 | 307 | 172 | 10 | int:SYNGAP1 |
| Interaction | H2BC21 interactions | DNAJC13 ATRX ATAD5 PCLO RPS27A SRCAP ORC2 YEATS2 MSH6 UBA52 UBB ZZZ3 SGO2 QSER1 DNAH5 WDR48 | 3.18e-04 | 696 | 172 | 16 | int:H2BC21 |
| Interaction | CALM1 interactions | DNAJC13 MYLK ATRX CALR VPS13C UBR4 DNM1L ECT2 HYPK QSER1 HERC2 UTRN NOS2 HTT BRWD1 | 3.18e-04 | 626 | 172 | 15 | int:CALM1 |
| Interaction | PPP1R9B interactions | DMXL2 ANK2 MAP1A DSP CALR PCLO RTN4 SPTBN1 DNM1L PFKM ECT2 TRMT1L PLEC VAV1 WDR48 | 3.18e-04 | 626 | 172 | 15 | int:PPP1R9B |
| Interaction | TRIM28 interactions | PRPSAP1 ERCC2 OGT ATRX MAP1A ZCCHC8 UBR4 DNM1L RPS27A SRCAP ECT2 BIRC6 LDAH EMSY POLR3A YEATS2 MSH6 UBA52 UPF2 HYPK CEBPZ IK TOPORS DNAH5 TP53BP1 ZNF124 | 3.24e-04 | 1474 | 172 | 26 | int:TRIM28 |
| Interaction | PTPRS interactions | 3.48e-04 | 153 | 172 | 7 | int:PTPRS | |
| Interaction | FOXP3 interactions | ATAD5 ZCCHC8 DNM1L ORC2 MSH6 UBA52 ATXN2 CEBPZ TRMT1L PLEC IK VAV1 | 3.49e-04 | 432 | 172 | 12 | int:FOXP3 |
| Interaction | PTPN13 interactions | 3.52e-04 | 202 | 172 | 8 | int:PTPN13 | |
| Interaction | USP20 interactions | 4.01e-04 | 206 | 172 | 8 | int:USP20 | |
| Interaction | OAT interactions | 4.14e-04 | 207 | 172 | 8 | int:OAT | |
| Interaction | UBE2D2 interactions | 4.18e-04 | 318 | 172 | 10 | int:UBE2D2 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.10e-07 | 161 | 119 | 10 | 593 | |
| GeneFamily | Fibronectin type III domain containing | 1.12e-06 | 160 | 119 | 9 | 555 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 9.79e-06 | 21 | 119 | 4 | 813 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.11e-04 | 18 | 119 | 3 | 91 | |
| GeneFamily | Immunoglobulin like domain containing | 2.90e-04 | 193 | 119 | 7 | 594 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 7.34e-04 | 163 | 119 | 6 | 590 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 8.08e-04 | 28 | 119 | 3 | 745 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.17e-03 | 8 | 119 | 2 | 939 | |
| GeneFamily | ATAC complex | 3.20e-03 | 13 | 119 | 2 | 1058 | |
| GeneFamily | CD molecules|Type II classical cadherins | 3.20e-03 | 13 | 119 | 2 | 1186 | |
| GeneFamily | PDZ domain containing | 3.33e-03 | 152 | 119 | 5 | 1220 | |
| GeneFamily | Myosin heavy chains | 4.26e-03 | 15 | 119 | 2 | 1098 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SEMA4D VPS11 ZEB1 RAPGEF6 OGT ATRX RBBP6 VPS13C UBR4 TBC1D2B APBA2 PHTF2 ICE1 RPS27A YTHDC1 FOXJ3 BIRC6 LAX1 CCNT2 MALT1 RFTN1 UBA52 UBC MYLIP EIF4G2 IK UTRN VAV1 BRWD1 | 1.24e-07 | 1492 | 171 | 29 | M40023 |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP | PRPSAP1 DMXL2 DNAJC13 CEP162 PLEKHM1 UBB CAPN7 IK CDH5 ZNF124 | 7.93e-07 | 199 | 171 | 10 | M5239 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | DNAJC13 ATRX RBBP6 GDF15 DNM1L RPS27A ECT2 MIPOL1 MSH6 CEBPZ EIF4G2 OSBPL10 SGO2 QSER1 PLEC PLK4 KNL1 BRWD1 | 1.26e-06 | 721 | 171 | 18 | M10237 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | ERCC2 DNAJC13 OGT RBBP6 PHTF2 ICE1 GCH1 SIRPB1 RPS27A YTHDC1 TGM5 CCNT2 MSH6 RFTN1 ZZZ3 UPF2 CEBPZ KRT20 MYH15 IK NOS2 PLK4 VAV1 EPB41 LRIT1 | 4.29e-06 | 1394 | 171 | 25 | M9585 |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP | 6.48e-06 | 198 | 171 | 9 | M5170 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | DMXL2 DCAF6 OGT ATRX MAP1A KALRN PCLO RTN4 PEG3 APBA2 DNM1L GCH1 CCDC92 PFKM ECT2 AKAP12 UBC ATP2C1 ASMTL OSBPL10 HERC2 ADGRL2 CDH11 | 6.97e-06 | 1248 | 171 | 23 | M17728 |
| Coexpression | GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN | 7.03e-06 | 200 | 171 | 9 | M9055 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DMXL2 DNAJC13 ZEB1 OGT ATRX ZFYVE16 FOXJ3 FAM171A1 ORC2 MALT1 MSH6 RFTN1 ATP2C1 ZZZ3 UPF2 ATXN2 ARHGAP29 TP53BP1 | 1.34e-05 | 856 | 171 | 18 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.23e-05 | 177 | 171 | 8 | M39245 | |
| Coexpression | PILON_KLF1_TARGETS_UP | MYLK PEG3 ESAM DNM1L EMSY WDR19 PTPRD PTPRF AMOT ARHGAP29 SERPINC1 DDHD2 CDH5 | 2.81e-05 | 503 | 171 | 13 | M2226 |
| Coexpression | GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP | 3.05e-05 | 185 | 171 | 8 | M5643 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_UP | 4.44e-05 | 195 | 171 | 8 | M9984 | |
| Coexpression | JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN | 4.55e-05 | 60 | 171 | 5 | M1515 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 5.31e-05 | 200 | 171 | 8 | M8030 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_DN | 5.31e-05 | 200 | 171 | 8 | M9650 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN | 5.31e-05 | 200 | 171 | 8 | M9935 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 5.31e-05 | 200 | 171 | 8 | M7518 | |
| Coexpression | PILON_KLF1_TARGETS_UP | MYLK PEG3 ESAM DNM1L EMSY WDR19 PTPRD PTPRF AMOT ARHGAP29 SERPINC1 DDHD2 CDH5 | 5.92e-05 | 541 | 171 | 13 | MM1061 |
| Coexpression | LAKE_ADULT_KIDNEY_C9_THIN_ASCENDING_LIMB | 7.03e-05 | 268 | 171 | 9 | M39228 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 7.36e-05 | 155 | 171 | 7 | M39246 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | SEMA4D ATAD5 VPS13C SPTBN1 PHTF2 GCH1 ECT2 CCDC7 MIPOL1 MSH6 ARHGAP29 OSBPL10 SGO2 HERC2 PLK4 KNL1 RPAP2 | 7.95e-05 | 892 | 171 | 17 | M18120 |
| Coexpression | AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2 | 1.00e-04 | 219 | 171 | 8 | M39111 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 1.13e-04 | 166 | 171 | 7 | M8129 | |
| Coexpression | MATZUK_MEIOTIC_AND_DNA_REPAIR | 1.20e-04 | 39 | 171 | 4 | M1819 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | DCAF6 ATRX VPS13C YTHDC1 TASOR2 UPF2 CAPN7 ARHGAP29 TRAK2 TRMT1L HERC2 | 1.26e-04 | 429 | 171 | 11 | M29 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | SEMA4D ZEB1 OGT RBBP6 APBA2 PBX4 YTHDC1 FOXJ3 TASOR2 CCNT2 MYLIP | 1.34e-04 | 432 | 171 | 11 | M41149 |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | DSP SPTBN1 ESAM FAM171A1 MALT1 ARHGAP29 AFDN ADGRL2 UTRN CDH5 CDH11 | 1.57e-04 | 440 | 171 | 11 | M39039 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | DMXL2 ATRX MAP1A DSP VPS13C PCLO RTN4 PEG3 FOXJ3 UBC ZZZ3 ATXN2 CAPN7 SCN1B KIF13A DNAH5 UTRN | 1.61e-04 | 946 | 171 | 17 | M39169 |
| Coexpression | GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN | 1.80e-04 | 179 | 171 | 7 | M6689 | |
| Coexpression | LAKE_ADULT_KIDNEY_C23_ENDOTHELIAL_CELLS_AVR | 1.82e-04 | 126 | 171 | 6 | M39242 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.86e-04 | 180 | 171 | 7 | M8239 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | DMXL2 OGT ZFYVE16 KALRN RTN4 GCH1 YTHDC1 AKAP12 MSH6 UBC UPF2 ASMTL IK NOS1 | 2.28e-04 | 705 | 171 | 14 | M1410 |
| Coexpression | STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP | 2.54e-04 | 134 | 171 | 6 | MM748 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | DNAJC13 OGT ATRX FOXJ3 FAM171A1 ORC2 RFTN1 ZZZ3 UPF2 ATXN2 ARHGAP29 | 2.57e-04 | 466 | 171 | 11 | M13522 |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 2.68e-04 | 191 | 171 | 7 | M40019 | |
| Coexpression | AIZARANI_LIVER_C4_EPCAM_POS_BILE_DUCT_CELLS_1 | 2.68e-04 | 191 | 171 | 7 | M39108 | |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN | 2.77e-04 | 192 | 171 | 7 | M6064 | |
| Coexpression | VEGF_A_UP.V1_DN | 2.85e-04 | 193 | 171 | 7 | M2675 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 2.87e-04 | 137 | 171 | 6 | M39241 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN | 3.04e-04 | 195 | 171 | 7 | M9808 | |
| Coexpression | GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP | 3.13e-04 | 196 | 171 | 7 | M4954 | |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN | 3.23e-04 | 197 | 171 | 7 | M8464 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | ZEB1 PHTF2 DNM1L ECT2 MIPOL1 MSH6 CEBPZ SOCS4 EIF4G2 SGO2 GFM1 KNL1 BRWD1 | 3.28e-04 | 644 | 171 | 13 | M10501 |
| Coexpression | GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN | 3.43e-04 | 199 | 171 | 7 | M7690 | |
| Coexpression | GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP | 3.43e-04 | 199 | 171 | 7 | M7821 | |
| Coexpression | GSE11057_CD4_EFF_MEM_VS_PBMC_UP | 3.43e-04 | 199 | 171 | 7 | M3113 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 3.43e-04 | 199 | 171 | 7 | M9184 | |
| Coexpression | TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_2_CELL | 3.45e-04 | 405 | 171 | 10 | M41667 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 3.54e-04 | 200 | 171 | 7 | M291 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN | 3.54e-04 | 200 | 171 | 7 | M9361 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP | 3.54e-04 | 200 | 171 | 7 | M9301 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN | 3.54e-04 | 200 | 171 | 7 | M9588 | |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN | 3.54e-04 | 200 | 171 | 7 | M3488 | |
| Coexpression | GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN | 3.54e-04 | 200 | 171 | 7 | M8654 | |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP | 3.54e-04 | 200 | 171 | 7 | M8469 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP | 3.54e-04 | 200 | 171 | 7 | M8484 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_6H_BMDC_DN | 3.54e-04 | 200 | 171 | 7 | M3944 | |
| Coexpression | GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN | 3.54e-04 | 200 | 171 | 7 | M7495 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 3.54e-04 | 200 | 171 | 7 | M6661 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN | 3.54e-04 | 200 | 171 | 7 | M6610 | |
| Coexpression | GSE18148_CBFB_KO_VS_WT_TREG_DN | 3.54e-04 | 200 | 171 | 7 | M4252 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_BASOPHIL_DN | 3.54e-04 | 200 | 171 | 7 | M5525 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP | 3.54e-04 | 200 | 171 | 7 | M5613 | |
| Coexpression | GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP | 3.54e-04 | 200 | 171 | 7 | M5668 | |
| Coexpression | CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN | 3.71e-04 | 52 | 171 | 4 | M12895 | |
| Coexpression | BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN | 3.71e-04 | 52 | 171 | 4 | M12518 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP | 3.89e-04 | 145 | 171 | 6 | M3045 | |
| Coexpression | OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP | 4.03e-04 | 146 | 171 | 6 | M41190 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | 4.76e-04 | 422 | 171 | 10 | M7396 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 4.79e-04 | 276 | 171 | 8 | M3063 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 4.88e-04 | 211 | 171 | 7 | MM17081 | |
| Coexpression | LAKE_ADULT_KIDNEY_C8_DECENDING_THIN_LIMB | 5.02e-04 | 278 | 171 | 8 | M39227 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.18e-06 | 127 | 169 | 8 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ATAD5 VPS13C PCLO RTN4 BIRC6 MSH6 ATP2C1 CEBPZ EIF4G2 SGO2 TRMT1L CEP126 TOPORS PLK4 EPB41 | 2.42e-05 | 532 | 169 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | IL13RA2 DMXL2 DCAF6 DNAJC13 ATRX SPTBN1 PEG3 PHTF2 SRCAP ECT2 BIRC6 IFNAR1 FAM204A ARHGAP29 PLEC NOS1 UTRN GABRA4 | 5.07e-05 | 778 | 169 | 18 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | DCAF6 DNAJC13 MYLK ATRX SPTBN1 PEG3 SRCAP BIRC6 OLFML3 IFNAR1 FAM204A ATXN2 PLEC TOPORS UTRN HTT KNL1 GABRA4 | 6.16e-05 | 790 | 169 | 18 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | IL13RA2 DMXL2 DCAF6 DNAJC13 ATRX SPTBN1 PEG3 PHTF2 SRCAP BIRC6 IFNAR1 FAM204A ATXN2 ARHGAP29 PLEC UTRN HTT GABRA4 | 6.68e-05 | 795 | 169 | 18 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | ZEB1 ATRX RBBP6 ATAD5 TBC1D2B PHTF2 ECT2 OLFML3 AKAP12 PTPRD CSRNP3 AMOT SOCS4 SGO2 PLCH1 ADGRL2 CDH11 BRWD1 | 9.73e-05 | 819 | 169 | 18 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.78e-05 | 230 | 169 | 9 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | DNAJC13 ATRX SPTBN1 PEG3 SRCAP ECT2 BIRC6 IFNAR1 FAM204A CSRNP3 UTRN GABRA4 | 1.11e-04 | 409 | 169 | 12 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.39e-04 | 241 | 169 | 9 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | IL13RA2 DMXL2 DCAF6 DNAJC13 ATRX SPTBN1 PEG3 PHTF2 SRCAP ECT2 BIRC6 TASOR2 IFNAR1 FAM204A ARHGAP29 UTRN GABRA4 | 1.59e-04 | 776 | 169 | 17 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ZEB1 RAPGEF6 ATRX ATAD5 ZGRF1 DNM1L ICE1 YTHDC1 ZZZ3 UPF2 QSER1 UTRN KNL1 BRWD1 | 1.75e-04 | 564 | 169 | 14 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ZEB1 ATRX SPTBN1 ESAM BIRC6 FAM171A1 ARHGAP29 AFDN ADGRL2 UTRN CDH5 BRWD1 | 2.32e-11 | 200 | 173 | 12 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.24e-09 | 179 | 173 | 10 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.92e-09 | 184 | 173 | 10 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | distal-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.21e-09 | 199 | 173 | 10 | bf70c8bfe932bccac5014e55f82019c5148627e7 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ZEB1 SPTBN1 ESAM SCN1B ARHGAP29 AFDN PLEC ADGRL2 KIF13A CDH5 | 6.51e-09 | 200 | 173 | 10 | 7034f57e282982c19c13ee8ab78eabaffa069e30 |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MYLK KALRN RTN4 SPTBN1 ESAM AKAP12 NFKB2 ARHGAP29 ADGRL2 CDH5 | 6.51e-09 | 200 | 173 | 10 | 16a70cc07dcfb4eba4385b712f27010c6629ff67 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-08 | 184 | 173 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-08 | 184 | 173 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-08 | 184 | 173 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.79e-08 | 185 | 173 | 9 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 5.76e-08 | 189 | 173 | 9 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.03e-08 | 190 | 173 | 9 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 7.21e-08 | 194 | 173 | 9 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.58e-08 | 198 | 173 | 9 | 0c8ec287500c58938ecc0dbbbc5f6c7a48733fc6 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.96e-08 | 199 | 173 | 9 | 9021f4be004efd51bb3658e5bbff53589356b3df | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.35e-08 | 200 | 173 | 9 | 3653002c805c314043e2a7b0c9980dfe952dc53e | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 9.35e-08 | 200 | 173 | 9 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.35e-08 | 200 | 173 | 9 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.35e-08 | 200 | 173 | 9 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 9.35e-08 | 200 | 173 | 9 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 9.35e-08 | 200 | 173 | 9 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.35e-08 | 200 | 173 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.35e-08 | 200 | 173 | 9 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 9.35e-08 | 200 | 173 | 9 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.41e-07 | 180 | 173 | 8 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.64e-07 | 181 | 173 | 8 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.88e-07 | 182 | 173 | 8 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.93e-07 | 186 | 173 | 8 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-07 | 186 | 173 | 8 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-07 | 186 | 173 | 8 | 10565fce7e1b4ec88bc8e1ed6410a83800be5014 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.93e-07 | 186 | 173 | 8 | 2b3c814a7dee8286ea113c63dc3de5daf0257d37 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 7.21e-07 | 187 | 173 | 8 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.82e-07 | 189 | 173 | 8 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 7.82e-07 | 189 | 173 | 8 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | 8.13e-07 | 190 | 173 | 8 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.13e-07 | 190 | 173 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 8.46e-07 | 191 | 173 | 8 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.46e-07 | 191 | 173 | 8 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 8.80e-07 | 192 | 173 | 8 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.80e-07 | 192 | 173 | 8 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.15e-07 | 193 | 173 | 8 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 9.15e-07 | 193 | 173 | 8 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.15e-07 | 193 | 173 | 8 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 9.15e-07 | 193 | 173 | 8 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.15e-07 | 193 | 173 | 8 | aaf681f16f310168e4719464814a1fc0a2f8431a | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.52e-07 | 194 | 173 | 8 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 9.52e-07 | 194 | 173 | 8 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.89e-07 | 195 | 173 | 8 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.89e-07 | 195 | 173 | 8 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.89e-07 | 195 | 173 | 8 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.89e-07 | 195 | 173 | 8 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.89e-07 | 195 | 173 | 8 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.89e-07 | 195 | 173 | 8 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-06 | 197 | 173 | 8 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.15e-06 | 199 | 173 | 8 | 84e30c39c2f050aa64af167999824c1cba32ba05 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-06 | 199 | 173 | 8 | 14a7c4cf4bb3d43fd32ec9cc74f6625b225ffaa1 | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.15e-06 | 199 | 173 | 8 | f1039d1ab498fc58f0feba545df05833c235db74 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 1.15e-06 | 199 | 173 | 8 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | medial-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.15e-06 | 199 | 173 | 8 | c5048b31649a0b7eddcd481b0458ed96508f5561 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-06 | 199 | 173 | 8 | 7ed541309808f15d65a9c4b26be2050e077539e6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 1.15e-06 | 199 | 173 | 8 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.15e-06 | 199 | 173 | 8 | 80c8641cfd84436eadf2234f1313749e2f73331f | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | 66f7e8ee63c828f17468e79a4b816346b33e8980 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.20e-06 | 200 | 173 | 8 | b91f8eb67752a77e1e08e462e50f1b5923695e1b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | distal-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.20e-06 | 200 | 173 | 8 | 7a355c3883fd409b2e0868164bb6e7ce4b745776 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 173 | 8 | 89a6da2bdedc6b1ad0675c8753bf2b763a99af6a | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.99e-06 | 166 | 173 | 7 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.32e-06 | 168 | 173 | 7 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 4.49e-06 | 169 | 173 | 7 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 169 | 173 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.65e-06 | 175 | 173 | 7 | 282f09bbdfa70d93b3f66591dcfb84c5ee0268c7 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 6.79e-06 | 180 | 173 | 7 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.79e-06 | 180 | 173 | 7 | b35a8c6169f4b548b912af005e92ae7c6596f376 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 7.05e-06 | 181 | 173 | 7 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 7.05e-06 | 181 | 173 | 7 | 61608123959483ff60f07d8467996853c4371b6a | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.30e-06 | 182 | 173 | 7 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.84e-06 | 184 | 173 | 7 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.84e-06 | 184 | 173 | 7 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-06 | 184 | 173 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.84e-06 | 184 | 173 | 7 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 7.84e-06 | 184 | 173 | 7 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.84e-06 | 184 | 173 | 7 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 7.84e-06 | 184 | 173 | 7 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 7.84e-06 | 184 | 173 | 7 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 8.13e-06 | 185 | 173 | 7 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 8.13e-06 | 185 | 173 | 7 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.42e-06 | 186 | 173 | 7 | f28d72b47624b69a580b4429e2be560a26898591 | |
| Drug | A-52 | 1.48e-06 | 12 | 172 | 4 | CID000120355 | |
| Drug | Shikoccin | 1.69e-06 | 4 | 172 | 3 | CID000327536 | |
| Drug | Ula 1 | 1.69e-06 | 4 | 172 | 3 | CID003047135 | |
| Drug | uranium-bromide | 1.69e-06 | 4 | 172 | 3 | CID000083507 | |
| Drug | AC1L9UW6 | 2.13e-06 | 13 | 172 | 4 | CID000456427 | |
| Drug | Methamphetamine | VPS11 SPATA6L HTR2B MYLK MAP1A ZFYVE16 DSP GDF15 UBR4 ICE1 GCH1 RPS27A PFKM ECT2 EMSY NDST3 UBC P2RX4 PTPRS EIF4G2 ARHGAP29 PLEC HERC2 NOS1 UTRN NOS2 SERPINA5 BRWD1 | 2.20e-06 | 1401 | 172 | 28 | ctd:D008694 |
| Drug | Papet | 4.19e-06 | 5 | 172 | 3 | CID005310950 | |
| Drug | 4-(oxyacetyl)phenoxyacetic acid | 4.19e-06 | 5 | 172 | 3 | CID000170173 | |
| Drug | NSC92535 | 1.23e-05 | 40 | 172 | 5 | CID000260803 | |
| Drug | psychotrine | 1.23e-05 | 40 | 172 | 5 | CID005462438 | |
| Drug | L2-G | 1.45e-05 | 7 | 172 | 3 | CID009549184 | |
| Drug | Glycopyrrolate [596-51-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.75e-05 | 194 | 172 | 9 | 4709_UP | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; MCF7; HT_HG-U133A | 1.82e-05 | 195 | 172 | 9 | 3459_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.82e-05 | 195 | 172 | 9 | 2071_DN | |
| Drug | Levonordefrin [829-74-3]; Down 200; 21.8uM; MCF7; HT_HG-U133A | 2.06e-05 | 198 | 172 | 9 | 3450_DN | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.14e-05 | 199 | 172 | 9 | 6214_UP | |
| Drug | AC1L2Y08 | CALR ESAM DNM1L RPS27A PFKM UBA52 UBB UBC CAPN7 NFKB2 NOS1 NOS2 HTT | 2.62e-05 | 432 | 172 | 13 | CID000105082 |
| Drug | beta-CCM | 2.97e-05 | 24 | 172 | 4 | CID000107704 | |
| Drug | M6 - t | 3.44e-05 | 9 | 172 | 3 | CID004477692 | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.08e-05 | 172 | 172 | 8 | 910_UP | |
| Drug | 4-oxo-2-butenoic acid | 5.67e-05 | 2 | 172 | 2 | CID000074088 | |
| Drug | N-Omega-Propyl-L-Arginine | 5.67e-05 | 2 | 172 | 2 | DB02644 | |
| Drug | UCH-L3 inhibitor | 5.67e-05 | 2 | 172 | 2 | CID002729042 | |
| Drug | N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine | 5.67e-05 | 2 | 172 | 2 | DB03449 | |
| Drug | UIr | 6.69e-05 | 11 | 172 | 3 | CID005326920 | |
| Drug | iodoacetamide | 7.27e-05 | 181 | 172 | 8 | CID000003727 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 7.27e-05 | 181 | 172 | 8 | 1077_UP | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 7.85e-05 | 183 | 172 | 8 | 1074_UP | |
| Drug | lycorine | 8.87e-05 | 12 | 172 | 3 | ctd:C015330 | |
| Drug | thaliporphine | 8.87e-05 | 12 | 172 | 3 | CID000100020 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 9.13e-05 | 187 | 172 | 8 | 2474_UP | |
| Drug | MnTM-2-PyP5+ | 9.59e-05 | 32 | 172 | 4 | CID000153503 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.02e-04 | 190 | 172 | 8 | 2721_UP | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.06e-04 | 191 | 172 | 8 | 4168_DN | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; HL60; HT_HG-U133A | 1.10e-04 | 192 | 172 | 8 | 3046_DN | |
| Drug | rosiglitazone; Up 200; 10uM; HL60; HT_HG-U133A | 1.10e-04 | 192 | 172 | 8 | 1174_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 1.14e-04 | 193 | 172 | 8 | 1079_UP | |
| Drug | 4 pN | 1.15e-04 | 13 | 172 | 3 | CID000078607 | |
| Drug | CV-6504 | 1.15e-04 | 13 | 172 | 3 | CID000093543 | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 1.18e-04 | 194 | 172 | 8 | 1180_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.22e-04 | 195 | 172 | 8 | 4748_DN | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.22e-04 | 195 | 172 | 8 | 5359_DN | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.26e-04 | 196 | 172 | 8 | 2755_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.26e-04 | 196 | 172 | 8 | 4419_DN | |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 1.26e-04 | 196 | 172 | 8 | 4420_DN | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.26e-04 | 196 | 172 | 8 | 3875_UP | |
| Drug | Chrysin [480-40-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.26e-04 | 196 | 172 | 8 | 5505_DN | |
| Drug | Sulindac [38194-50-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.31e-04 | 197 | 172 | 8 | 5528_UP | |
| Drug | Diloxanide furoate [3736-81-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.31e-04 | 197 | 172 | 8 | 3399_UP | |
| Drug | Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 1.31e-04 | 197 | 172 | 8 | 1507_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 172 | 8 | 4995_DN | |
| Drug | PF-01378883-00 [351320-41-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 172 | 8 | 6363_DN | |
| Drug | 5140203; Up 200; 15uM; MCF7; HT_HG-U133A_EA | 1.36e-04 | 198 | 172 | 8 | 908_UP | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 172 | 8 | 1688_UP | |
| Drug | Propidium iodide [25535-16-4]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 172 | 8 | 6104_DN | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 172 | 8 | 3292_DN | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 172 | 8 | 3540_DN | |
| Drug | Guanadrel sulfate [22195-34-2]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.36e-04 | 198 | 172 | 8 | 2575_DN | |
| Drug | Niacin [59-67-6]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 172 | 8 | 3381_UP | |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 172 | 8 | 5420_DN | |
| Drug | N-acetylserotonin | 1.37e-04 | 35 | 172 | 4 | CID000000903 | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.40e-04 | 199 | 172 | 8 | 1055_DN | |
| Drug | 3-aminobenzamide; Down 200; 10000uM; MCF7; HG-U133A | 1.40e-04 | 199 | 172 | 8 | 590_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.40e-04 | 199 | 172 | 8 | 4765_DN | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.40e-04 | 199 | 172 | 8 | 3011_DN | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.40e-04 | 199 | 172 | 8 | 1493_DN | |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; HL60; HT_HG-U133A | 1.45e-04 | 200 | 172 | 8 | 2575_UP | |
| Drug | milrinone | 1.48e-04 | 150 | 172 | 7 | CID000004197 | |
| Drug | FG 7142 | 1.53e-04 | 36 | 172 | 4 | CID000004375 | |
| Drug | 3-Bromo-7-Nitroindazole | 1.69e-04 | 3 | 172 | 2 | DB01997 | |
| Drug | NSC730494 | 1.69e-04 | 3 | 172 | 2 | CID009604735 | |
| Drug | N-(3-(Aminomethyl)Benzyl)Acetamidine | 1.69e-04 | 3 | 172 | 2 | DB02044 | |
| Drug | trifluoperazine | 1.86e-04 | 324 | 172 | 10 | CID000005566 | |
| Disease | Colorectal Carcinoma | ERCC2 ANK2 KALRN CALR RTN4 PEG3 PBX4 AKAP12 NDST3 MSH6 ZZZ3 SIGLEC7 PTPRD CSRNP3 GUCY2C PTPRS KRT20 CDH5 IQUB | 1.83e-08 | 702 | 166 | 19 | C0009402 |
| Disease | azoospermia (implicated_via_orthology) | 1.53e-05 | 27 | 166 | 4 | DOID:14227 (implicated_via_orthology) | |
| Disease | semaphorin-4D measurement | 1.87e-04 | 4 | 166 | 2 | EFO_0802050 | |
| Disease | mucositis (biomarker_via_orthology) | 3.11e-04 | 5 | 166 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | temperament and character inventory | 3.24e-04 | 24 | 166 | 3 | EFO_0004825 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 3.55e-04 | 107 | 166 | 5 | DOID:6000 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | MYH1 ZEB1 ANK2 KALRN UBR4 ECT2 EMSY AKAP12 MSH6 PTPRD ARHGAP29 HERC2 NOS2 CDH5 TP53BP1 GABRA4 | 3.88e-04 | 1074 | 166 | 16 | C0006142 |
| Disease | apolipoprotein B measurement | ANKRD31 ERCC2 DNAJC13 CYP20A1 PBX4 CCDC92 LDAH ATXN2 MYLIP PLEC HTT BRWD1 | 3.94e-04 | 663 | 166 | 12 | EFO_0004615 |
| Disease | Myocardial Ischemia | 4.99e-04 | 176 | 166 | 6 | C0151744 | |
| Disease | prostate carcinoma | ANK2 PBX4 LDAH EMSY TASOR2 MIPOL1 YEATS2 PTPRD UPF2 GUCY2C QSER1 ADGRL2 KIF13A KNL1 | 5.39e-04 | 891 | 166 | 14 | EFO_0001663 |
| Disease | quinolinate measurement | 6.49e-04 | 7 | 166 | 2 | EFO_0800175 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 7.00e-04 | 71 | 166 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | intellectual disability (implicated_via_orthology) | 8.61e-04 | 75 | 166 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Vasogenic Brain Edema | 8.61e-04 | 8 | 166 | 2 | C0750969 | |
| Disease | Cytotoxic Brain Edema | 8.61e-04 | 8 | 166 | 2 | C0750970 | |
| Disease | Cytotoxic Cerebral Edema | 8.61e-04 | 8 | 166 | 2 | C0472388 | |
| Disease | Vasogenic Cerebral Edema | 8.61e-04 | 8 | 166 | 2 | C0472387 | |
| Disease | cocaine use disorder, social environment measurement | 8.61e-04 | 8 | 166 | 2 | EFO_0010445, EFO_0010552 | |
| Disease | Brain Edema | 8.61e-04 | 8 | 166 | 2 | C1527311 | |
| Disease | Cerebral Edema | 8.61e-04 | 8 | 166 | 2 | C0006114 | |
| Disease | sialic acid-binding Ig-like lectin 9 measurement | 1.10e-03 | 9 | 166 | 2 | EFO_0008286 | |
| Disease | sialic acid-binding ig-like lectin 7 measurement | 1.10e-03 | 9 | 166 | 2 | EFO_0020739 | |
| Disease | t-cell surface glycoprotein CD5 measurement | 1.10e-03 | 9 | 166 | 2 | EFO_0803134 | |
| Disease | Spastic Paraplegia | 1.10e-03 | 9 | 166 | 2 | C0037772 | |
| Disease | executive function measurement | 1.36e-03 | 376 | 166 | 8 | EFO_0009332 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.37e-03 | 10 | 166 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.37e-03 | 10 | 166 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.37e-03 | 10 | 166 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.37e-03 | 10 | 166 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.37e-03 | 10 | 166 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.37e-03 | 10 | 166 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.37e-03 | 10 | 166 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.37e-03 | 10 | 166 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (is_marker_for) | 1.38e-03 | 39 | 166 | 3 | DOID:12930 (is_marker_for) | |
| Disease | glaucoma | 1.83e-03 | 154 | 166 | 5 | MONDO_0005041 | |
| Disease | mean platelet volume | SPATA6L PCDHGB7 PCDHGB5 KALRN ATAD5 PCDHGA9 SPTBN1 DNM1L SIRPB1 SRCAP ATXN2 PLEC VAV1 HTT | 1.94e-03 | 1020 | 166 | 14 | EFO_0004584 |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 2.00e-03 | 12 | 166 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 2.00e-03 | 12 | 166 | 2 | C3160718 | |
| Disease | distal myopathy (implicated_via_orthology) | 2.00e-03 | 12 | 166 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.00e-03 | 12 | 166 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | Myeloproliferative disease | 2.00e-03 | 12 | 166 | 2 | C0027022 | |
| Disease | platelet measurement | 2.12e-03 | 315 | 166 | 7 | EFO_0005036 | |
| Disease | epilepsy (implicated_via_orthology) | 2.34e-03 | 163 | 166 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.36e-03 | 13 | 166 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 2.36e-03 | 13 | 166 | 2 | C1846647 | |
| Disease | dystonia (is_implicated_in) | 2.74e-03 | 14 | 166 | 2 | DOID:543 (is_implicated_in) | |
| Disease | Manganese Poisoning | 2.74e-03 | 14 | 166 | 2 | C0677050 | |
| Disease | revision of total hip arthroplasty | 2.74e-03 | 14 | 166 | 2 | EFO_0020973 | |
| Disease | 5-methyluridine (ribothymidine) measurement | 2.74e-03 | 14 | 166 | 2 | EFO_0020013 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.15e-03 | 15 | 166 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 3.15e-03 | 15 | 166 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Ischemic stroke, fibrinogen measurement | 3.70e-03 | 55 | 166 | 3 | EFO_0004623, HP_0002140 | |
| Disease | grip strength measurement | 3.79e-03 | 350 | 166 | 7 | EFO_0006941 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.91e-03 | 264 | 166 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | immature platelet fraction | 3.99e-03 | 114 | 166 | 4 | EFO_0009187 | |
| Disease | otitis media (biomarker_via_orthology) | 4.05e-03 | 17 | 166 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | cognitive function measurement, self reported educational attainment | 4.09e-03 | 355 | 166 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 4.10e-03 | 57 | 166 | 3 | EFO_0022284 | |
| Disease | dental caries | 4.21e-03 | 187 | 166 | 5 | EFO_0003819 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 4.51e-03 | 59 | 166 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | alcohol consumption measurement | GDF15 PCLO RTN4 SPTBN1 CYP20A1 BIRC6 WDR19 NDST3 ZZZ3 PLCH1 ADGRL2 DNAH5 CDH11 HTT GABRA4 | 4.51e-03 | 1242 | 166 | 15 | EFO_0007878 |
| Disease | disease free survival | 4.54e-03 | 18 | 166 | 2 | EFO_0000409 | |
| Disease | immature platelet measurement | 4.65e-03 | 119 | 166 | 4 | EFO_0803541 | |
| Disease | free cholesterol in very large VLDL measurement | 4.96e-03 | 61 | 166 | 3 | EFO_0022274 | |
| Disease | alkaline phosphatase measurement | DNAJC13 MAP1A SIGLEC9 GDF15 SPTBN1 CYP20A1 PBX4 PLEKHM1 CSRNP3 ATXN2 UTRN ALPK2 TP53BP1 | 5.00e-03 | 1015 | 166 | 13 | EFO_0004533 |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 5.05e-03 | 19 | 166 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 5.05e-03 | 19 | 166 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | aspartate aminotransferase measurement | ANKRD31 DNAJC13 RAPGEF6 KALRN PBX4 BIRC6 PLEKHM1 PTPRD ATXN2 ARHGAP29 ALPK2 ARL14 | 5.26e-03 | 904 | 166 | 12 | EFO_0004736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ETSITTEKELNQYFE | 36 | Q9Y3F1 | |
| QYITVSKEELSSGDS | 1496 | P55196 | |
| VDEIVKSGYISESEN | 296 | Q96QE3 | |
| KSGYISESENSEISQ | 301 | Q96QE3 | |
| QYSTQNLPSEKEDTE | 21 | Q5W0A0 | |
| ETKTITYEAAQTDDN | 761 | P11171 | |
| LTENEGDKTEEQVSY | 466 | P41595 | |
| EYEGSEDTRKTISQL | 526 | Q4VCS5 | |
| EQLYSQKQETSLSGS | 361 | O60583 | |
| KEGTEEQDTFVSVIY | 931 | Q9NR09 | |
| EVSVAENQSYKSPSE | 516 | Q96M83 | |
| NTIEGTAKYIETSEL | 346 | O00429 | |
| DLKYEQSISEANDET | 736 | Q86TB3 | |
| SILSKTEGTQEADQY | 1256 | Q02952 | |
| TEGTQEADQYADEKT | 1261 | Q02952 | |
| SVYQDNESETGKNSI | 326 | O95490 | |
| EDLSQKEYSDIINTQ | 536 | Q99767 | |
| NTDGLVYVVDSTDKQ | 81 | Q8N4G2 | |
| SEESTKIPQSYEDQT | 1446 | Q8TDJ6 | |
| EESSEDVTKYQEGVS | 541 | Q58WW2 | |
| DKSLTFNETYQDISE | 181 | P01008 | |
| YNLTVEAKELDSTGT | 441 | P33151 | |
| TDEPKTETESNVNAY | 51 | Q9H8W3 | |
| LYSKTSQSVSGEEID | 586 | P98194 | |
| KEGITDTAQTIYETA | 2001 | Q96BY7 | |
| ATVENETYTLKTTNE | 286 | Q14627 | |
| GYKQENELSETASEV | 36 | O95803 | |
| GNVTENLQTYIDKST | 266 | Q9H8K7 | |
| EKGYQETDSVVSSVT | 51 | Q99571 | |
| SDGEINAQESTYKVS | 586 | Q2KHR3 | |
| TEDSKTIQGYDAIVV | 361 | Q14699 | |
| KENLLIGSTSYVEEE | 31 | Q9H8V3 | |
| GTLEYLQLNTTDKES | 1056 | P25092 | |
| TEKIYVLDGTQNDTA | 166 | Q9NRN5 | |
| ATDQDEGINSEITYS | 266 | Q9Y5F8 | |
| TLPIYTKESESDQEQ | 1451 | Q01484 | |
| TEYSQKENDLTEATD | 1556 | Q8N7Z5 | |
| VEAVTKEIETTGTYQ | 166 | P35228 | |
| KEIETTGTYQLTGDE | 171 | P35228 | |
| QNEDATQYEESILTK | 66 | P0C881 | |
| QNEDASQYEESILTK | 66 | B2RC85 | |
| KGQTTLIQYTSNAED | 4966 | Q99102 | |
| TQLVYLDDVEQSGSE | 786 | Q5VUB5 | |
| TVTINTEQKVSDFYD | 1451 | Q15746 | |
| VAELEEEQSQGSSSY | 106 | P78559 | |
| QYSGLEDTVEDKQEV | 691 | Q9UDY8 | |
| ETDSQYTSAVTENIK | 186 | Q9UQ53 | |
| SYLEQETTGINKSTQ | 11 | Q8TD10 | |
| KDGEIVYTGTESTQN | 41 | O95714 | |
| GLLEKTEQGYSNTET | 346 | O95671 | |
| SEEEKYTAVQRNSSE | 466 | Q99700 | |
| SENYSERDTVKNGTL | 451 | Q8WYN3 | |
| KNSSGVEERIENIYS | 171 | P17181 | |
| KTYEEVQSIISQQSG | 4566 | Q9Y6V0 | |
| ENTGEISTAKSLDYE | 296 | Q9Y5G4 | |
| TDEEATKSSYLNIVG | 146 | P08237 | |
| GETTEETQELLKEYG | 1161 | O60229 | |
| SEDSQQLEEAYSSGK | 61 | O94830 | |
| SNEDSSDYENVLTAK | 366 | Q8IWV1 | |
| KELEGTSQASAEYQV | 161 | Q8WY64 | |
| TQDGAETSVALEKYQ | 571 | P18074 | |
| ETNSRESKGNDITIY | 326 | Q8NG31 | |
| KESSSLVQYDLIGQT | 216 | P48169 | |
| QKTDTGVSLQTYDDL | 286 | Q99988 | |
| TESGEYSRQLDEKDT | 1286 | P12882 | |
| ATDQDEGINSEITYS | 266 | Q9Y5G0 | |
| GTTYVTDKSEEDNEI | 211 | P52701 | |
| EDGRTLSDYNIQKES | 51 | P62987 | |
| GEDVKTTEYQLSTLE | 376 | P35900 | |
| KLTETVVTEYLNSGN | 546 | P78344 | |
| ELVESNEKGESSIYI | 851 | Q9GZU2 | |
| NKDSTEATVTYVNLE | 561 | Q9P2V4 | |
| LQITNAQTKEEYTDD | 46 | Q7Z6E9 | |
| YNESDSESNVSVKEE | 1641 | Q7Z6E9 | |
| LEEVNKEIDTTSTYQ | 386 | P29475 | |
| ENITYKNISSGEIEL | 806 | Q9UMZ3 | |
| LQIESSEETDQGKYE | 201 | Q13332 | |
| QEEATIYTGKTAVDT | 276 | Q9BYU1 | |
| QEYSEFVKATNSTEE | 461 | Q52LW3 | |
| QSESSNYDSELEKEI | 811 | P46100 | |
| SDSSEIVLDGTDNQY | 576 | P42858 | |
| IESEEDDYSLKNTSQ | 1236 | Q9Y2F5 | |
| SNATQYEDTGDLKVN | 76 | Q9NZS2 | |
| SAETKETERQIYQQD | 66 | Q5T0U0 | |
| AGSSLENIQEKITEY | 46 | Q9Y6W3 | |
| TVTNKVTLYNTDQDG | 206 | Q9UPW0 | |
| DLTYELTVKSSEQTG | 61 | Q53HC0 | |
| DQEKYSELNQENGTT | 436 | Q9P2H0 | |
| STVNELESGQISYDE | 2231 | P15924 | |
| KGTQEQDFYVTSETV | 216 | P05154 | |
| CGYLEEEEESTTVQK | 141 | Q8NCU4 | |
| GEKYIEEALTSISSQ | 236 | Q5T764 | |
| TYEVKIDNSQVESGS | 181 | P27797 | |
| FEITTDYETQEGVIK | 316 | P55287 | |
| NKTYRSQLSSEEEGA | 466 | Q5TB80 | |
| LNVYKEDDTTINSES | 2281 | Q9NSI6 | |
| YTLEESGIQKSEETN | 1556 | O75165 | |
| EDQVLSYINGVTTSK | 81 | Q96AP7 | |
| EKYEAQNIVNSTEES | 6 | Q8NA54 | |
| KSVVYQETNGETRVE | 36 | Q14558 | |
| IQEGKEEPQNYTDSS | 706 | Q7Z589 | |
| ENTGKVTEEEDVYIN | 3046 | Q8NDH2 | |
| EGQVIETKYELVTSS | 436 | Q6UW02 | |
| STQEDVINKYLEATG | 726 | Q96RP9 | |
| YSQTGDDKVREQIDT | 496 | Q03701 | |
| KTYSVLQDSTIEGLE | 491 | Q8TE73 | |
| ALQIESSEESDQGKY | 191 | P10586 | |
| QETSPAEVAEQYSEK | 681 | O15294 | |
| ALQIEQSEESDQGKY | 191 | P23468 | |
| TDYLTDSNKENETDE | 1076 | Q9HAU5 | |
| SKNTNTSDEIIGLSY | 296 | Q8NGV5 | |
| EELDSKQNTVSYQDL | 16 | Q9UPX6 | |
| SENEGTSDGETYIEK | 1331 | Q9H1H9 | |
| EETSYENSLLVKQSG | 456 | Q13416 | |
| TSTGALYIKDVQNED | 176 | O60469 | |
| KQYVSLDTVVTSEDG | 31 | Q9Y4G2 | |
| SELNEVTGTKIAYET | 561 | Q9NQC3 | |
| GSDDTRNVKETTEYL | 2406 | P46939 | |
| SIDKSTETDNGYVSL | 266 | Q8N3S3 | |
| QNKEDSTSEVNYIIE | 361 | Q8N4H0 | |
| TDDTTTDNYIAQGKR | 596 | Q7Z2T5 | |
| NYKGERQTITDDVEV | 146 | Q8TEU7 | |
| LKNTYEESIVGQETL | 1496 | Q9Y2K3 | |
| TKGYQETISDVLNDA | 106 | P30793 | |
| TTSNNTYEVEKTLGI | 1246 | O14802 | |
| YSDAETVNGIEKTEV | 46 | Q8WXH5 | |
| GETITSEKYAQEIDE | 551 | Q53H47 | |
| SGQEATNNEYSEIKI | 451 | Q9Y286 | |
| QGQEATDSEYSEIKI | 461 | Q9NYZ4 | |
| SRGQEATDTEYSEIK | 446 | Q9Y336 | |
| TKDSGNLYDSEIQNV | 771 | Q562F6 | |
| GSEDTTNEDYQSIAL | 1001 | Q8NEZ3 | |
| LDTGYETEQDTITSK | 811 | Q92854 | |
| YAEEKEIQSSNLETA | 41 | Q9NX55 | |
| IVGQTEKYSDLLSQS | 236 | Q6ZRS2 | |
| EYVKEVLQISSDGNT | 631 | O00444 | |
| TYNNGETKVIDTTTL | 666 | Q9BXB5 | |
| DSDYKGEIQLVISSS | 721 | P63128 | |
| TNVSQSKDSDVYITD | 31 | P01848 | |
| ETASTLTENKDGTYN | 296 | Q5TFQ8 | |
| SQIQSDDYGKDLTSV | 1401 | Q01082 | |
| YEADTTEEQTGKTFT | 406 | Q13733 | |
| LQLSDFYTEDTKEQS | 151 | Q5U649 | |
| ETASTLIENKDGTYN | 296 | O00241 | |
| TETVTYEEKEQQLVS | 236 | O60296 | |
| TEVGEIQQNKSVTYD | 346 | Q6NZY4 | |
| KYTGVTDSTETQEDQ | 1081 | A4D1E1 | |
| VTTENVQSYIVSGKD | 206 | Q9H270 | |
| LTVNGKTENYILDTT | 31 | Q6UXZ0 | |
| YEKIINLDNESQTTS | 601 | Q8TAF3 | |
| YVLGEETTKSQDSEE | 471 | Q8IXW5 | |
| TNVSQSKDSDVYITD | 166 | P0DTU3 | |
| EIQQTEEKYTDTLGS | 201 | P15498 | |
| NASEYLAITSESKEN | 196 | Q07699 | |
| NESKQEVSYIGITSS | 3101 | Q709C8 | |
| NKDYEETELISTTAN | 111 | Q13123 | |
| DKEQLQSVTTNSGYT | 191 | Q12888 | |
| KVQSGSESVIQEYVD | 1441 | Q15149 | |
| SIQSDERDDITENYK | 431 | O43548 | |
| EDGRTLSDYNIQKES | 51 | P0CG47 | |
| SSQSSKEEVNSEEYG | 166 | Q96MU7 | |
| YSTDDEEDTQQSTGK | 566 | Q4KWH8 | |
| GEDQSIEDQYKNSSR | 56 | Q15973 | |
| DQDGTTKIIINYSLE | 466 | P37275 | |
| ETVKTQEQEQSYSSG | 511 | Q9NS56 | |
| EVNTCGTLEKEYEQS | 461 | Q86YA3 | |
| GESSQVSEDENYVIK | 146 | A6NK53 | |
| VSEDENYVIKLQGES | 151 | A6NK53 | |
| KSTEGTETIEGVYNT | 416 | Q86VQ6 | |
| YNNEVTGEEAKQESL | 916 | Q5VWN6 | |
| QLEDGGTEYVIATTK | 566 | Q96AX1 | |
| QELIQEYEDSGGSKT | 676 | Q9NV66 | |
| EDGRTLSDYNIQKES | 51 | P0CG48 | |
| DGRTLSDYNIQKEST | 356 | P0CG48 | |
| EDGRTLSDYNIQKES | 431 | P0CG48 | |
| QQVRTGSTSSKEDDY | 356 | Q5T4S7 | |
| EDGRTLSDYNIQKES | 51 | P62979 | |
| SYVLQEKSVAENGDT | 231 | Q8IYH5 | |
| KTLYLTENQEVSTGV | 621 | Q9UPU7 | |
| QTAVKTEESSELGNY | 1126 | Q9ULM3 | |
| TEESSELGNYVIKID | 1131 | Q9ULM3 | |
| ELGIKVDTTLSDSYN | 206 | Q7Z3T8 | |
| TTSEDSNAQEIKDIY | 96 | Q9H6V9 | |
| IIQNLSEEDKGSYTA | 1066 | Q5VTT5 | |
| TITIEKVNSEDSGRY | 1391 | Q5VTT5 | |
| EVKEDSAYGSQSVEQ | 861 | Q00653 |